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METABOLIC MID ENDOCRINE ASPECTS 
OF CORONARY DISEASE 
I N T R O D U C T I O N 
The name arteriosclerosis was first used 
by Lobstein (1829 -1833) to describe hardening of 
the arteries. It is a generic term for three 
distinct lesions, which are probably most 
satisfactorily defined in pathological terms. 
Atherosclerosis 
Atherosclerosis is the name first intro- 
duced by Marchand (1904) to describe lesions of 
the arterial intima, which are characterised by 
focal thickening and the presence of lipid 
material in and between the cellular elements. 
At one extreme there may be marked fibrosis and 
minimal lipid deposition, and at the other there 
may be little fibrosis and massive lipid de- 
position and necrosis; it is from this soft 
yellow pultaceous material that the disease 
derives the prefix athero (or, in Greek, athere 
In 




atheromatous lesion is the fatty and fibrous 
intimai plaque; these plaques are patchy and 
irregular and occlude the arterial lumen to a 
greater or lesser degree. Major and moderate 
sized vessels are involved, particularly the 
aorta, the coronary, cerebral and mesenteric 
arteries. 
Medial Sclerosis 
A different type of arteriosclerosis was 
described by Mönckeberg (1903). It consists of 
necrosis and calcification of the media and is 
not necessarily associated with intimal lesions. 
Medium sized arteries, such as the arteries of 
the extremities and the temporal arteries, are 
most commonly involved; calcification occurs in 
circular and plate -like masses and cause gross 
distortion of the arterial wall and the pipe -stem 
hardening familiar to the clinician. 
Diffuse Arteriolar Sclerosis 
A third type of arteriosclerosis involves 
small arteries, particularly of the viscera, 
100 microns or less in diameter. The lesions 
are characterised by subintimal hyaline thickening 
and elastic hyperplasia, and are particularly 
marked in the renal arteries in association with 
hypertension. 
3. 
It is exclusively with atherosclerosis 
that thesis is concerned. The pleomorphism of 
atherosclerotic lesions, which range from the 
purely fibrous to the fatty necrotic deposit, 
is so remarkable that it is unlikely that any 
single aetiological concept will explain their 
derivation. There have been two fundamentally 
different approaches to the problem of the 
aetiology of atherosclerosis: one holds that 
atherosclerosis is the inevitable result of 
advancing years, and the other postulates that 
it is an active and potentially reversible process 
not exclusively associated with age. 
The ageing theory of atherogenesis has 
received support from the fact that the incidence 
and extent of atherosclerotic lesions increases 
with age. Atherosclerosis is regarded as an 
irreversible process which will eventually over- 
come us all, provided we survive long enough. 
Moschowitz (1942), in his monograph on vascular 
sclerosis, concluded "it is hardly likely that 
any method of therapy will ever be discovered 
which will restore diseased vessels to their 
normal texture. Nor can arteriosclerosis be 
prevented, no more than grey hair or facial 
wrinkles." Whereas the histological and physico- 
chemical/ 
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chemical tissue changes which are associated 
with advancing years undoubtedly contribute to 
the production of vascular lesions, they do not 
wholly explain some of the established facts 
concerning atherosclerosis. Any theory of the 
genesis of atherosclerosis must provide plausible 
explanations for the following facts, which will 
be elaborated during the course of this thesis: 
atherosclerotic lesions may be absent in advanced 
age and present in childhood, and they are common 
in early adult life; atherosclerotic lesions 
involve the arterial tree in an irregular and 
patchy distribution; there is a definite re- 
lation between the incidence of atherosclerotic 
lesions with sex and with race; and atherosclerotic 
lesions can be produced experimentally in various 
species by differing chemical and physical agents. 
These observations are most satisfactorily explain- 
ed by regarding atherosclerosis as an active 
disease rather than solely as an incurable con- 
sequence of ageing. 
In general, atherosclerosis involves the 
abdominal aorta more extensively and earlier than 
any other vessel, but slight extrusion of intimai 
plaques have little significant effect on the 
lumen,/ 
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lumen, whereas similar intimai thickening in 
the coronary or cerebral arteries may cause 
partial or total occlusion of the lumen. The 
incidence of atherosclerosis in the coronary 
arteries is not much less than that of the aorta, 
but clearly the consequence of coronary athero- 
sclerosis are more disasterous than those of 
aortic atherosclerosis. It is, therefore, the 
aetiology of atherosclerosis of the coronary 
arteries that is the particular subject of this 
thesis. 
THE PURPOSE OF THIS THESIS 
The purpose of this thesis is twofold. 
First, to examine the nature and significance 
of certain metabolic abnormalities associated 
with ischaemic heart disease. Second, to 
propose and expound a thesis that disturbance 
of the physiological balance of the endocrine 
glands could contribute to the production of 
these metabolic abnormalities and to the develop- 
ment of coronary atherosclerosis, and thus be 
of major importance in the aetiology of ischaemic 
heart disease. 
The thesis is divided into four principle 
parts. The first part concerns the development 
of atherosclerosis of the coronary arteries, and 
the relationship of coronary atherosclerosis to 
ischaemic heart disease. The second part des- 
cribes the nature and influences of the circulating 
lipids and lipoproteins in health, and the 
abnormalities associated with ischaemic heart dis- 
ease. The third part contains the exposition 
of the thesis that an endocrine imbalance could 
act as an aetiological factor in the development 
of/ 
7. 
of ischaemic heart disease. The fourth part 
deals with some of the therapeutic implications 
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9. 
A. ATHEROSCLEROTIC TRSIONS. 
1. The early history of hardening of the 
arteries. 
It is now known that aortic atheroma 
occurred 3,500 years ago. Examination of 
Egyptian and Coptic mummies, who lived between 
1580 B.C. and 525 A.D., revealed extensive patchy 
atheroma and calcification in the remains of the 
abdominal and thoracic aortae (Ruffer, 1910, 1911); 
and Shattock (1909) found calcified atheroma in 
the aorta of Menephtah, the Pharaoh of the Exodus. 
Unfortunately examination of these mummies gave 
no information about the presence of coronary 
atheroma as the embalming process always entailed 
removal of the heart. The Egyptians, Greeks and 
Romas gave little consideration to cardiac path- 
ology, and their knowledge of physiology and 
anatomy was mostly speculative. Thus there was 
a gap of many centuries until Bonetus (1678) 
described in the Sephulchretum the case of a 
fat middle -aged poet who succumbed in a few 
minutes after the onset of "distress in breathing ": 
autopsy revealed ossified coronary arteries, which 
were almost, if not completely, occluded and 
Bonetus considered that this state of the vessels 
was responsible for the symptoms. Ossification 
of the coronary arteries had been reported on a 
few occasions before Crell wrote at length in 
1740 concerning hardening of the coronary arteries. 
He observed/ 
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He observed that the arterial incrustations 
were not bony but of a tophaceous nature, and 
believed that this induration came from the viscid 
juices of the blood. He considered that these 
lesions occurred at any age and were not necess- 
arily confined to advanced age. Von Haller (1755), 
in the course of careful dissection, found a 
yellow juice between the muscular fibres and the 
tunica intima of the arterial wall. He consid- 
ered that this yellow juice gradually hardened 
and was the cause of ossification of the arteries. 
This accurate localisation of the site of the 
atheromatous lesion preceded Virchow's classic 
work by a hundred years, but it appears to have 
excited little attention and did not receive 
confirmation until the following century. 
Scarpa (1804) described steatomatous and ulcer- 
ative degeneration of the intimai coat of arteries 
but thought that it was related to lues venera. 
Subsequently there were several reports 
incriminating syphilis as a cause of these lesions, 
and it was not until 1875 that the first accurate 
histological differentiation between the mes- 
aortitis of syphilis and the atheromatous 
intimai lesion was made by Welch. Virchow (1856) 
emphasised/ 
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emphasised the patchy distribution of athero- 
sclerotic lesions; he described in detail the 
sites of arterial lesions and considered that 
local changes in haemodynamics and mechanical 
forces are important in their production. 
Evidence that the coronary arteries are 
necessary for the maintenance of cardiac function 
was first provided by Chirac in 1698 when he tied 
the coronary artery of a dog and observed that 
soon after the heart had ceased to beat. In 
1809 Burns, in a book published in Edinburgh, 
likened the impairment of the heart's function 
when the coronary arteries are diseased to the 
inability of a limb to continue any vigorous action 
if it has had a ligature placed tightly at its 
base. He obviously appreciated the importance 
of adequate blood supply for normal function and 
believed the blood supply to be impaired by 
ossified coronary arteries. Hodgson (1815) 
emphasised the importance of collateral circula- 
tion and arteries when the major coronary arteries 
are atherosclerotic. Hope (1832) recognised 
that osseous,cartilagenous and steatomatous 
degeneration of the coronary arteries is associat- 
ed with loss of their elasticity. Hall (1812) 
believed that sudden death was often due to arrest 
of the coronary circulation. He outlined some 
investigations/ 
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investigations for testing his hypothesis in 
animals and it was confirmed by Erichsen (1842), 
who repeated Chirac's original experiment and 
ligated the coronary arteries in dogs. He 
recognised that any circumstance that interferes 
with the passage of blood through the coronary 
arteries, either directly as in ossification of 
the coats of those vessels, or indirectly because 
of a reduction in ventricular output, may cause 
death. 
2. The relation of cholesterol to 
atherosclerotic lesions. 
The name "Cholesterine" was first used 
by Chevreul (1816) to describe the crystalline 
substance in gallstones. In 18)E11 Becquerel and 
Rodier stated that there is cholesterol in the 
blood and that it increases with advancing years 
after the age of LSO. Three years later Vogel 
(18L17) showed that the steatomatous arterial 
degeneration described by Scarpa (1804) is due 
to deposits of cholesterol; he considered that 
the presence of these deposits was probably 
dependent on an excess of cholesterol in the 
blood. Virchow (1856) also believed that 
atheromatous lesions resulted from a primary 
imbibition from the blood, and he did not believe 
that/ 
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that this was purely passive because an almost 
neoplastic proliferation of the intimai connective 
tissue preceded any fatty degeneration and 
softening. Lipoidal masses in the aorta are 
doubly retractile because of the presence of 
cholesterol esters (Mettenheimer, 1857), and the 
fat content of the aorta increases with the 
severity of the atherosclerosis (Gazert, 1899). 
Aschoff (1906) emphasised the great abundance 
of cholesterol esters in aortic atheroma, and 
Windaus (1910) undertook for Aschoff the chemical 
analysis of atheromatous aortae and found that 
they contain 7 times as much free cholesterol and 
20 to 26 times as much ester -cholesterol as 
normal aortae. 
Whereas the presence of cholesterol in 
the atheromatous lesion had been recognised for 
a number of years, its significance was not fully 
appreciated until Anitschkow and Chalatow (1913) 
succeeded in producing a fairly typical picture 
of atherosclerosis by feeding rabbits pure 
cholesterol dissolved in vegetable oil. Since 
these early experiments atherosclerotic lesions, 
characterised initially by the presence of fine 
fat droplets and foam cells in the extracellular 
ground/ 
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ground substance, have been produced repeatedly 
in rabbits, dogs and chicks as a result of the 
addition of cholesterol to the diet. Similar 
arterial lesions have been produced by the 
parenteral administration of cholesterol emulsions 
(Pollak, 1949) and the intravenous administration 
to normal rabbits of hypercholesterolaemic plasma 
from cholesterol -fed rabbits (Bradgon, 1D52). 
In the human the lipid composition of athero- 
sclerotic plaques (Buck and Rossiter, 1951) and 
of the plasma is similar enough to suggest that 
the lipids of the plaques have their origin in the 
plasma (Weinhouse and Hirsch, 1940) . The oral 
feeding of tritium- labelled cholesterol to men 
has resulted in its demonstration in the plasma 
and subsequently in aortic atherosclerotic plaques 
(Biggs et al, 1952), and this indicates, therefore, 
that exogenous cholesterol enters into the 
metabolism of the atherosclerotic human aorta. 
In most species the extent and number of cholest- 
erol- induced atheroslcerotic lesions is proportion - 
1 to the degree of hypercholesterolaemia 
(Anitschkow, 1933; Katz and Stamler, 1953); this 
oes not indicate, however, that preceding 
hypercholesterolaemia/ 
15. 
hypercholesterolaemia is a sine qua non for the 
development of typical atheromatous lesions, 
since such lesions can develop at sites of local 
anoxia which may favour precipitation of 
cholesterol in the intima. 
3. The relation of blood coagulation to 
atherosclerotic lesions. 
Ideas concerning the formation of fibrin 
and thrombi were confused and vague until the era 
of Rokitansky and Virchow. Rokitansky (1841 -46) 
believed that excessive fibrin deposition on the 
and 
arterial intima leads to intima]/subintimal 
hypertrophy, atheroma and ossification. Many 
eminent physicians of the early part of the 19th 
century considered that fibrin formation and 
subsequent thrombosis was the result of inflam- 
mation of the arterial wall, and Cruveilhier 
(1849 -62) wrote extensively on intravascular 
clotting and asserted that phlebitis was not only 
the cause of thrombosis but that it "dominated 
all pathology ". He considered that an arteritis 
was the foundation of arterial clots, and that the 
pultaceous matter of atheromatous ulcers was 
carried by the blood and deposited on arterial 
walls where inflammation occurred. The subse- 
quent erosions were then repaired by local clottir 
of the blood. Virchow (1858) was convinced 
that/ 
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that "inflammation of the blood" was much 
misunderstood. He studied thrombi and the 
process of their formation most systematically 
and stressed the importance of changes in the 
blood itself, slowing of the circulation and 
non-inflammatory changes in the vessel wall. 
In subsequent years pathologists and 
physicians were primarily interested in throm- 
bosis as a cause of occlusion of a coronary 
artery with the resultant acute classical clinical 
picture. It was not until recently that Duguid 
(1946, 1949) re- examined Rokitansky's original 
concept and produced clear -cut evidence that 
some atherosclerotic lesions result from organ- 
isation of fibrin deposits on the intimal surface. 
Duguid maintains that anoxaemia and fatty degen- 
eration occur deep to the fibrin deposit which 
becomes covered with endothelium and incorporated 
into the arterial wall. The degree of narrowing 
of an atherosclerotic coronary artery is difficult 
to assess at autopsy for in life the blood 
pressure tends to iron out excrescences and 
maintain a smooth intimal lining and full lumen. 
Indeed, Duguid and Robertson (1955) believe that 
a vessel which is atherosclerotic is dilated 
during life and that narrowing of the lumen 
results/ 
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results from fibrin deposition and thrombosis. 
There is little doubt that fibrin deposition 
contributes towards the production of arterial 
intimai lesions; it is probable, however, that 
the lesions which depend primarily on fibrin 
deposition are predominantly fibrous in nature. 
L1.. The coronary circulation and the develop- 
ment of atherosclerotic lesions 
Although the aorta is the vessel in which 
atherosclerosis attains its earliest and most 
extensive expression (Willius et al, 1933; Albert, 
1938), the coronary arteries are far more exten- 
sively involved than arteries of corresponding 
size. Certain characteristics of the coronary 
circulation may explain this selection. 
The relationship between extravascular 
and intravascular pressure may be important in 
the development of atherosclerosis. Coronary 
arteries which penetrate the myocardium are rarely 
the site of atheroma (Duff and Mc.illan, 1951; 
Geiringer, 1951) probably because the extra - 
vascular systolic pressure, produced by the con- 
tracting myocardium, is equal to or greater than 
the intravascular pressure; thus there is 
virtually no passage of lipid material from the 
lumen/ 
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lumen into the wall of an artery penetrating 
the myocardium. Furthermore, muscular con- 
traction has the effect of massaging any small 
amount of lipid material from the site of 
penetration to a site subject to less violent 
extravascular pressure, such as the subepicardial 
arteries. In the subepicardial vessels the 
lesions are most prominent in the part of the 
subintimal region nearest to the myocardium 
(Wolkoff, 1929) , possibly because of the greater 
external movement at this side, but when the 
artery lies below a bridge of myocardium, the 
buried portion is said to be more uniformly 
involved and generally less subject to the disease 
(Geiringer, 1951), although this observation has 
recently been contested (Edwards et al, 1956). 
Subepicardial vessels are commonly the site of 
atheromatous deposits and generally such deposits 
occur where intravascular pressure is greatest. 
When the flow of blood through intramuscular 
myocardial arteries is more or less arrested in 
systole, the velocity head in the subepicardial 
vessels is impeded and the lateral pressure head 
is augmented. The resultant high lateral systolic 
pressure against the walls of the subepicardial 
vessels/ 
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vessels may favour lipid deposition, particularly 
in vessels supplying the left ventricle. The 
intramural systolic pressure is lower in the 
right ventricle and atria, and thus the right 
coronary and the circumflex branch of the left 
coronary artery are often less involved than the 
left anterior descending artery. 
There is a definite relationship between 
the sites of lipid deposition and areas where 
the uniform blood flow is disturbed (Dock, 1950) . 
The base of the aorta is exposed to rhythmic and 
violent vibration and frequently has gross athero- 
sclerotic lesions; the anterior cusp of the 
mitral valve and the welids undergo regular 
movement and are common sites for lipid deposition. 
When the intramural portions of the myocardial 
coronary arteries are more or less occluded during 
systole, the blood in the subepicardial portion 
of the arteries undergoes turbulence and thus lipid 
deposition may be potentiated. Local narrowing, 
bifurcations and tortuosity are all associated with 
turbulence of the blood. Disturbance of uniform 
blood flow can result in instability of the plasma 
colloidal equilibrium and could favour cholesterol 
deposition (Hueper, 195). 
The/ 
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The intima of the coronary arteries is 
developmentally thicker than other arteries and 
this thickness increases with age (Wolkoff, 1923; 
Gross et a1. 1934). Dock (1946) demonstrated 
eccentric intimai thickenings in newborn infants 
and showed that the newborn male coronary intima 
is 22 times as thick as that of the newborn 
female; he thought that these thickenings were 
developmental irregularities which favoured the 
subsequent occurrence of atherosclerosis in these 
areas, although Fangman and Hellwig (1927) con- 
cluded that they were early atherosclerotic 
lesions. These intimai thickenings occur in 
varying degree in a large number of newborn 
infants of both sexes, and their distribution 
resembles that of the adult atherosclerotic lesion 
(Minkowski, 1947) . 
5. Incidence of coronary atherosclerosis. 
Coronary atherosclerosis was not described 
before the 17th century, yet it is now found 
almost universally in adult civilised communities. 
It is difficult to determine how much this 
represents a true increase in incidence, how much 
it is a result of the development of anatomical 
and pathological skill and how much it is due to 
the/ 
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the increased expectation of life enabling more 
people to reach an age when coronary athero- 
sclerosis is prevalent. For instance, Morris 
(1951) concluded, from an analysis of the records 
of the London Hospital between 1908 and 1949, that 
there was no increase in the incidence of coronary 
atheroma in routine autopsies during these 42 
years. Although the incidence of atherosclerosis 
increases with advancing age (Ophiils, 1926), the 
extent and degree of atherosclerotic lesions are 
by no means dependent on age. Typical athero- 
sclerotic lesions have been reported from time 
to time in children and there is no doubt that 
atherosclerosis of the coronary arteries occurs 
frequently in young adults. Studies of the 
coronary arteries of battle casualties in World 
War I showed atherosclerosis in 11% of youths 
between 15 and 20 years of age and 23% of men 
between 25 and 30 (R6ssle, 1919) , and in 51% 
of 652 autopsies performed on men between 17 
and 45 (M3nckeberg, 1916). Similarly, Enos 
et al (1953) demonstrated well- marked coronary 
atherosclerosis in ?7% of United States service 
men killed in action in Korea, and their average 
age was only 22 years. Conversely, comparatively 
minimal/ 
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minimal atherosclerosis was observed in one -third 
of a series of autopsies in patients dying from 
all causes over the age of 80 ( Groddeck, 1939). 
Atherosclerotic lesions are present in 
the coronary arteries in the majority of the adult 
inhabitants of the civilised communities of the 
world. Severe and extensive coronary athero- 
sclerosis was reported in 40% of autopsies per- 
formed in men between the ages of 40 and 49, and 
in 75% of the autopsies in men between the ages 
of 50 and 59 (White et al, 1950). Blumgart 
(1951) reported complete occlusion, or marked 
narrowing of one or more major coronary arteries, 
in 40¡6 of men who died of non -cardiac causes after 
the age of 40. These estimates refer to extensive 
atheromatous lesions of the coronary arteries 
but Friedberg and Horn (1939) showed that myo- 
cardial infarction, necrosis and fibrosis can 
all occur without gross coronary atherosclerosis 
and occlusion. Intrusion into the lumen of a 
major coronary artery by one or two comparatively 
small, but critically placed, atheromatous de- 
posits may be sufficient to reduce the supply of 
blood below the demands of the myocardium. Such 
lesions may act as sites for thrombus formation 
with further luminal narrowing, and, whether or 
not/ 
23. 
not thrombosis occurs, a few discrete lesions 
can lead to myocardial infarction. Thus, it is 
not only the gross and extensive atherosclerotic 
lesions which are important. 
B. CLINICAL FEATURES OF CORONARY ATHEROSCUROSIS 
1. The early history of chest pain, angina 
pectoris and coronary thrombosis. 
From the time of the Egyptian and Greek 
civilisations it was thought that the heart was 
immune from disease. This concept was handed 
down over the centuries and was not seriously 
questioned until the beginning of the 17th 
century. 
a. Praecor dial pain 
William Harvey described, probably for 
the first time, the association of pain in the 
chest with myocardial disease. He recorded in 
1649 the case of "a noble knight, Sir Robert 
Darcy, when he had reached to about the middle 
period of life, made frequent complaint of a 
certain oppressive pain in the chest (' dolore 
quondam pectoris oppressivo') especially in the 
night season. The disease became worse and 
worse and he by and by became cachectic and 
dropsical, and finally died in one of his severely 
oppressive paroxysms ('in uno paroxissimo vehe- 
menter oppressus'). In his body the wall of the 
left / 
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left ventricle of the heart was ruptured, and 
there was a hole of such size as to admit any 
of my fingers although the ventricular wall 
appeared thick and strong ". The praecordial 
pain of coronary disease was first described by 
Morgagni (1769) in his celebrated "De Sedibus 
et Causis Morborum ". In October 1707 he ex- 
amined the body of a woman "the mother of a 
family, who was two -and -forty years of age, had 
liv'd long in a state of infirm health, and had 
long been subject to a kind of paroxysm, which 
appeared in the following manner: on using pretty 
quick exercise of body, a kind of violent un- 
easiness came on, within the upper part of the 
thorax, on the left side, join'd with a diffi- 
culty in breathing, and a numbness of the left 
arm: all of which symptoms soon remitted when 
these motions ceased ". On a journey to Venice 
in October, 1707 she had just such a paroxysm 
"and saying that she should die; she actually 
died on the spot ". Extensive irregular hard- 
ening and ossification was found throughout the 
entire length of the aorta. Morgagni described 
another patient whose symptoms suggested angina 
and in whom aortic ossification was found. In 
other cases he described atheromatous lesions, 
"prominence/ 
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"prominence and pustules ", in the coronary 
arteries. Morgagni himself died from a ruptured 
ventricle. 
b. Angina pectoris 
On July 2lst 1768, William Heberden read 
a paper to the Royal College of Physicians in 
London entitled "Some Account of a Disorder of 
the Breast ". He began "There is a disorder of 
the breast, marked with strong and peculiar 
symptoms, considerable for the kind of danger 
belonging to it, and not extremely rare, or 
which T do not recollect any mention amoyng 
medical authors. The seat of it and sense of 
strangling and anxiety with which it is attended, 
may make it not improperly be called Angina 
Pectoris ". He described the classical features 
of angina of effort and also nocturnal attacks 
lasting for hours. He also described the case 
of one man who may very well have had a coronary 
thrombosis; "And I have met with one, in whom 
it once continued for several days, during all 
of which time the patient seemed to be in imminent 
danger of death ". Heberden did not recognise 
that disease of the coronary arteries was the 
primary factor: "The pulse is 
not disturbed by this pain, and consequently the 
heart/ 
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heart is not affected by it; which I have had 
an opportunity of knowing by feeling the pulse, 
during the paroxysm;" 
In 1772 Heberden read a letter which he 
had received from an unkown sufferer of angina 
pectoris. He described the subsequent post- 
mortem which was performed by his friend John 
Hunter and said "no manifest cause of death could 
be discovered ". In the same year Wall wrote to 
Hebeden from Worcester and gave an account of the 
post -mortem examination of a man aged 66, who had 
had angina. He reported that "the semi -lunar 
valves, placed at the origin of the aorta, were 
found to be perfectly ossified ". It is inter- 
esting that the first case of angina, in which 
an abnormality was found within the heart, was 
due to calcific aortic stenosis and that in this 
case the coronary arteries were possibly not 
particularly diseased. In 1775 John Hunter 
describes the post -mortem of a man, who had died 
in a violent transport of anger and who had 
previously had angina of effort. "The two 
coronary arteries, from their origin to many 
of their ramifications upon the heart, were 
become one piece of bone ". In the following 
year/ 
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year 1776 Edward Jenner saw John Hunter in 
Bath, where the latter was convalescing after 
his second attack of angina pectoris, and wrote 
a most interesting letter to He'Lerden; he 
suggested for the first time the association of 
disease of the coronary arteries with angina 
pectoris. He had examined two hearts after 
death and "in the first I found no material 
disease of the heart, except that the coronary 
artery appeared thickened ". In the second he 
"found the same appearance of the coronary 
arteries as in the former case a kind 
of firm, fleshy tube formed within the vessels, 
with a considerable Quantity of ossific material 
dispersed irregularly through it. The importance 
of the coronaries, and how much the heart must 
suffer from their not being able to perform their 
functions (we cannot be surprised at the painful 
spasms), is a subject I need not enlarge upon, 
therefore I shall just remark that it is possible 
that all the symptoms may arise from this one 
circumstance Should it be admitted 
that this is the cause of the disease, I fear 
that the medical world may seek in vain for a 
remedy ". When John Hunter died in 1793 (17 years 
after/ 
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after Jenner put forward his hypothesis which 
was not published for fear that Hunter would 
read it) his coronary arteries were found to be 
converted into open bony tubes. By 1802 Hebérden 
was able to report that he had seen nearly 100 
patients with angina pectoris; the majority 
were men near or past 50, but included 3 women 
and 1 boy aged 12. 
At the beginning of the 19th century 
there were numberous reports of cases of angina 
pectoris but disease of the coronary arteries 
was by no means established as a cause. It 
was variously described as a nervous affliction 
of the heart or as a consequence of syphilis, 
and comparatively little attention was given to 
the conclusions of Jenner and Parry (1799) . 
Although there were numerous reports of cases 
of angina during the next 100 years, it was by 
no means common and it is remarkable that Sir 
William Osier (1897) saw dotal of only 40 cases 
during all his years of clinical experience. 
Osier did not see a single case of angina during 
the ten years of his private and hospital practice 
in Montreal, and he observed that "it is too 
narrow a view to suppose the aetiology identical 
with that of arteriosclerosis. The one is so 
common/ 
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common and the other comparatively rare ". 
Sir James Mackenzie, with his early experience 
in general practice and later as a leading 
cardiologist, wrote as late as 1923 that only 
380 patients had consulted him on account of 
angina pectoris. 
c. Coronary thrombosis. 
Thrombosis of a coronary artery wat con- 
firmed at autopsy and first diagnosed during 
life by Hammer (1876), and the first complete 
and accurate description of myocardial infarct- 
ion was made in 1880 by Weigert. Welch (1899) 
emphasised that coronary thrombosis occurred 
in relation to atherosclerosis of the coronary 
arteries. In 1910 Obrastzow and Straschesko 
presented the first complete clinical description 
of sudden occlusion of a coronary artery; they 
described three patients, two of whom were 
diagnosed correctly during life, who had autopsy 
evidence of a thrombosis of a coronary artery. 
Two years later Herrick (1912) elaborated the 
clinical features and indicated for the first 
time that sudden occlusibn of a coronary artery 
is not necessarily fatal. Despite these reports 
it was not until about 1920 that coronary 
thrombosis was seriously considered as/ 
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as an antemortem diagnosis. 
2. The incidence of ischaemic heart disease. 
In 1920 the crude mortality from 
ischaemic heart disease (see foot of page) was 
22 per million living but in 1955 it was 1575 
per million living (Registrar -General's Statis- 
tical Tables, England and Wales, 1920- 1955); 
this represents a seventy -fold increase (Fig. 1). 
A series of 3,000 patients suffering from some 
form of heart disease was assembled in 1925 and 
has recently been contrasted with a comparable 
series of 3,000 patients assembled by the same 
physician in 1950 (White, 1D53): the proportion 
of patients identified as suffering from ischae- 
mic heart disease was 20'ó in 1925 and 48.5;0 in 
1950. In a careful clinical and epidemiological 
survey Ryle and Russell (19L9) concluded that the 
increase in the incidence of ischaemic heart 
disease is real and probably not influenced 
greatly by changing fashions in death certifi- 
cation, such as the transference of cases from 
the designations of myocardial and cardiovascular 
degeneration to that of diseases of the coronary 
arteries and angina. 
Ischaemic heart disease is used to describe the 
international statistical classification of 
arteriosclerotic heprt ,is ,ease (420.0) , heart 
disease specified as /coro t ÿ arteries (420.1) 
and angina pectoris without specific mention of 
the coronary arteries (420.2). 
Fig. 1. The crude annual death rate from ischaemie 
heart disease per million persons living 
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The number of patients admitted annually 
with iscnaemic heart disease (angina or coronary 
thrombosis) to the medical wards of the Edinburgh 
Royal Infirmary has been determined and expressed 
as a percentage of the total annual medical 
admissions for all causes; a similar analysis 
has been made for patients with cerebral vascular 
disease. The records allowed analysis over the 
last 20 years and the results are shown in Figs. 
2 and 3. Wartime records were not very adequate 
and are probably inaccurate on account of the 
moving population and the occupation of part of 
the hospital by troops. Although this compara- 
tive analysis of morbidity rates is limited by 
the total number of available hospital beds, it 
suggests that there has been an increase in 
morbidity from coronary disease considerably in 
excess of the morbidity from cerebral vascular 
disease. A similar trend is seen, particularly 
in men, when the mortality from coronary heart 
disease and cerebral vascular disease are expressed 
as a percentage of the total mortality from all 
causes (Registrar- General's Statistical Tables 
for Scotland, 1937 -1955) (Figs. 4 and 5). 
It is hardly conceivable that this in- 
crease in the clinical manifestations of coronary 
atherosclerosis / 
Fig. 2. The number of patients with ischaemic 
heart disease admitited to the medical 
wards of the Edinburgh Royal Infirmary 
expressed as a percentage of the total 
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Fig. 3. The number of patients with cerebral 
vascular disease admitted to the medical 
wards of the Edinburgh Royal Infirmary 
expressed as a percentage of the total 
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atherosclerosis is entirely due to improved 
diagnosis in a population which is living longer, 
and it is likely that the increase both in 
morbidity and mortality from ischaemic heart 
disease represents a real rise in the incidence 
of the disease during the last 25 or 30 years. 
3. Incidence of coronary thrombosis. 
The term coronary thrombosis is most 
commonly used to describe the acute clinical 
features which accompany myocardial infarction 
and does not necessarily indicate whether or not 
there has been thrombotic occlusion of a coronary 
artery. It has already been indicated that 
coronary atherosclerosis may not be increasing 
very greatly, yet the incidence of ischaemic 
heart disease is rising rapidly. Since 
thrombosis of a coronary artery is a cause of 
ischaemic heart disease, it is important to assess: 
its incidence and, in order to do this, it is 
necessary to differentiate coronary thrombosis 
from myocardial infarction. Myocardial infarc- 
tion can occur with and without occlusion of a 
coronary artery. Occlusion of a coronary artery 
can be due to the formation of a thrombus within 
the artery, or due to gradual intrusion into the 
lumen by an atherosclerotic plaque; this latter 
(type/ 
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type of occlusion may not cause any symptoms 
during life as its gradual development allows the 
formation of adequate collateral vascular channels 
(Blumgart et al, 1941). When there is no 
occlusion, infarction can follow prolonged myo- 
cardial ischaemia resulting from any discrepancy 
between the blood supply and the metabolic demands 
of the myocardium. Friedberg and Horn (1939) 
did not observe occlusion in 31% of 91 cases of 
myocardial infarction, and by making close trans- 
verse sections faster et al (191111) found occlusion 
in only 48 of 100 cases of myocardial infarction. 
It is probable that only about half the 
cases of myocardial infarction have recent and 
occlusive thrombosis of a coronary artery. Yater 
et al (1948) examined 450 hearts from United States 
service men who died from ischaemic heart disease 
between the ages of 18 and 39 during World War II. 
All had advanced coronary atherosclerosis and 114 
had gross myocardial infarction; in 8 of these 
there was no occlusion of any coronary artery, in 
27 (24%) there was atherosclerotic occlusion only, 
in 55 (50 %) there was thrombotic occlusion only 
and in the remaining 27 there was both athero- 
sclerotic and thrombotic occlusion. Of the 336 
hearts/ 
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hearts without gross myocardial infarction, there 
were 38 without coronary occlusion, 148 OW 
with atherosclerotic occlusion only, 117 (357) 
with thrombotic occlusion only and in the remainin 
33 there was both atherosclerotic and thrombotic 
occlusion. Similarly, Branwood and Montgomery 
(1956) demonstrated by the use of a rapid and 
efficient slicing technique that thrombotic 
occlusion occurred in 2l¡ó and that atherosclerotic 
occlusion occurred in 18% of 61 cases of recent 
myocardial infarction; thus, the majority of 
their cases showed no occlusion of a coronary 
artery. In 26 subjects, who had a previous 
history of angina and died suddenly, there was 
gross coronary atherosclerosis but coronary 
occlusion in only eight; in 5 of these occlusion 
was due to a recent thrombus, and in the remaining 
3 occlusion was due to rupture from softened 
atheromatous plaques. any of the recent occlus- 
ive thrombi appeared to be of more recent origin 
than the related myocardial infarct and Branwood 
and Montgomery have suggested that some occlusive 
thrombi may develop as a terminal event after the 
establishment of the myocardial infarct. 
Early studies of coronary occlusion 
seldom differentiated thrombotic from atheromatous 
occlusion/ 
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occlusion and thus there is no satisfactory 
measure against which the present incidence of 
thrombotic occlusion may be contrasted. It is 
not possible, therefore, to decide whether the 
increasing incidence of ischaemic heart disease 
is partly due to an increase in the incidence of 
coronary thrombosis; all that can be said is 
that recent occlusive coronary thrombosis probably 
does not account for much more than half the cases 
of myocardial infarction. 
4. Prevalence of ischaemic heart disease. 
With the increase in the incidence of 
ischaemic heart disease, certain interesting 
features concerning the prevalence and distri- 
bution of coronary disease in the community have 
become apparent. 
a. AEe distribution. 
An analysis has been made of 1,000 
consecutive patients, who were admitted to the 
medical wards of the Edinburgh Royal Infirmary 
or the cardiac beds of the Western General 
Hospital, for treatment of a recent myocardial 
infarct; none of these patients had had a 
previous myocardial infarct and all had electro- 
cardiographic evidence of myocardial damage. 
The maximum incidence of acute myocardial 
infarction/ 
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infarction occurred in men between the ages of 
50 and 59, and in women ten years later between 
the ages of 60 and 69 (Fig. E and Table I). 
A recent analysis of 7,032 autopsies 
over 33 years has suggested that the overall 
frequency of deaths from atherosclerotic heart 
disease has not changed very greatly, but that 
there has been an increase in the incidence under 
the age of 50 (Saphir et al, 1956). In the 
course of 5 years 237 patients, who developed 
ischaemic heart disease under the age of 50, have 
been seen at the Department of Cardiology at 
but 
Edinburgh Royal Infirmary;/ expression of this 
figure as a percentage of the total patients does 
not give any accurate information of the true age 
distribution of the disease since many of these 
patients were specially referred to the Department 
because of the interest of the staff in coronary 
disease. Furthermore, analysis of the Regisixar- 
General's statistical reports does not offer any 
certain indication that the disease may be 
occurring with increasing frequency in younger 
age groups as it is not possible to allow for the 
increasing awareness of coronary disease by the 
medical profession and the whole population. 
b./ 
Fig. G. The age distribution of 1000 consecutive 
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b. Sex distribution. 
There is a remarkable difference in the 
incidence of clinical coronary disease between 
the sexes. Analysis of the sex distribution 
of the 1,000 consecutive admissions, referred to 
in the preceding subsection, has emphasised the 
male predominance at all ages and the infrequency 
of the disease in women during their reproductive 
years (Table I) (Oliver & Boyd, 1955c; Icussafia 
& Puddu, 1956). 
Table I. Sex and age distribution of 1,000 
consecutive patients with recent 
myocardial infarction. 
Age 
Numbers of cases Ratio of 
Men to 4on1en 
Yen !n'omen 
Younger than 35 19 1 19:1 
35 - 39 44 3 15:1 
40 - 49 188 26 7:1 
50 - 59 256 53 5 :1 
60 - 69 195 86 2 :1 
Older than 70 68 61 1 :1 
This sex difference is striking in civilised 
communities, but is much less marked in primitive 
communities such as the Bantus (Walker et alp 
1956), the Navaho Indians and the negroes in the 
U.S.A. (Weiss & Gray, 195L1). It appears that 
the sex difference is less evident in populations 
which are relatively free from coronary disease. 
There/ 
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There is less difference in the incidence of 
severe atherosclerotic lesions of the coronary 
arteries between the sexes when compared with the 
sex difference in ischaemic heart disease. The 
ratio of atherosclerotic lesions between men and 
women under the age of 11.0 is 4:3 (Lober, 1953), 
whereas the corresponding ratio for ischaemic 
heart disease is in the region of 10:1; similarly, 
there is no significant sex difference with re- 
gard to atherosclerotic lesions of the aorta 
(Boas and Epstein, 1954). 
c. Heredity. 
There is little doubt that hereditary 
factors play a part in the production of 
ischaemic heart disease and a family history can 
be obtained more often in young patients than in 
those who are older (Gertler et al, 1953). 
Comparison of the parental histories was made 
between 100 patients with ischaemic heart disease 
and 100 patients with malignant disease of the 
skin, nose and throat - there is no reported sex 
limiting influence in the incidence of cancer 
in these areas. The malignant 'control' group 
was matched in age and sex to the coronary group. 
This analysis (Table II) indicates that a history 
of angina or coronary thrombosis is more common 
in/ 
39. 
in the parents of patients with ischaemic heart 
disease than in the parents of patients with 
malignant disease. 
Table II. The incidence of coronary disease 
in the parents of patients with 








No parental history 76 90 
One parent with 
coronary disease 21 10 
Both parents with 
coronary disease ____/__ 0 
100 100 
A family history of ischaemic heart 
disease probably depends partly on the associated 
hypercholesterolaemia which occurs more often 
and to a greater extent in young subjects of 
coronary disease (see page 76); an example of 
this association of hypercholesterolaemia with 
a family history of ischaemic heart disease is 
shown in Fig. 7 . Hypercholesterolaemia is often 
inherited (Adlersberg et al, 1949) but its mode 
of inheritance is not yet understood. 
d. Body build./ 
Fig. 7. An example of ischaemic heart disease 
and hypercholesterolaemia in a family. 
The figures represent the plasma cholest- 
erol levels in m/. 
C.T. CANCER 
(DEAD) (DEAD) 
I I 1 I I I I 
? cif o 
C.T. C.T. HEALTHY CT. C.T. HEALTHY DIABETES 
(432) (DEAD) (305) (DEAD) (321) (246) (DIED AT 25) 
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d. Body build. 
Body build is largely determined by 
hereditary influences (Sheldon et al, 194.0). 
Coronary thrombosis has been reported to be more 
common in square muscular men tending to fatness 
(endomorphic mesomorphs) (Phipps, 1936; Gertler 
et al, 1953). An analysis was made of the 
somatotypes of 200 consecutive subjects (149 men 
and 51 women) with symptoms of coronary disease; 
there was electrocardiographic confirmation of 
myocardial infarction in 170 and of ischaemia 
before or after the Master two -step test in 30. 
This group was contrasted with 200 miscellaneous 
inpatients who had no history or clinical features 
of cardiac, renal, hepatic, metabolic or wasting 
disease; this control group was matched to the 
coronary group by age and sex. The height:weight 
ratio, or ponderal index, which is regarded as 
a useful measure of massiveness, was assessed in 





(Sheldon et al, 1940). The results are ex- 
pressed in Table III. In men with ischaemic 
heart disease over the age of 40 the ponderal 
indices differed significantly from the men of 
corresponding decades in the control group 
(P .0.05), but no significant difference was 
























































































































































































































































































































































































































































































































































































































































with coronary disease confirm that ischaemic 
heart disease occurs more commonly in endomorphic 
mesomorphs than in ectomorphs: mesomorphy is the 
component of masculinity, bone mass and angularity 
of outline and contour; ectomorphy is the com- 
ponent of linearity and elongation, while endo- 
morphy is the component of softness and roundness 
but not necessarily of fat. 
e. Prevalence in disease with abnormal 
lipid metabolism. 
Ischaemic heart disease and severe cor- 
onary atherosclerosis both occur commonly and 
prematurely in association with certain diseases 
in which there is disturbance of lipid metabolism 
and a hypercholesterolaemic tendency. In 
diabetes mellitus the incidence of coronary 
thrombosis and of coronary atherosclerosis is 
more than twice normal (see Part III Section B) 
and atherosclerosis has been regarded as almost 
universal in diabetes (Barach, 1949). Pronounced 
hyperlipaemia and hypercholesterolaemia are 
commonly found in association with diabetes 
(see Part III, Section C) . 
Similarly in hypothyroidism the incidence 
and severity of ischaemic heart disease and 
coronary atherosclerosis is increased (see Part 
III Section B) and there is hypercholesterolaemia 
(see/ 
42. 
(see Part III, Section 0). In chronic renal 
disease and the nephrotic syndrome there is a 
significant increase in atherosclerosis (Steiner 
& Domanski, 1942) and there is often gross 
hypercholesterolaemia (Peters & Man, 1943c). 
In familial hypercholesterolaemic xanthomatosis, 
the incidence of coronary atherosclerosis, which 
is greatly increased, directly parallels the 
degree of hypercholesterolaemia and occurs 
prematurely (Adlersberg et al, 1949). 
C. CONCLUSION. 
Atherosclerotic arterial lesions occurred 
thousands of years ago and there is no clear 
evidence that their incidence is increasing; 
the nature of the coronary circulation predisposes 
it to the development of atherosclerotic lesions 
which are present in the vast majority of the ad- 
ult members of the civilised communities of the 
world. In contrast, ischaemic heart disease, 
which was uncommon before this century, accounted 
for 20% of all the deaths in Britain in 1955 
(Registrar-General's Statistical Tables, England 
and Wales, and Scotland, 1955) . There is a 
striking male predominance, particularly under 
the age of 50, in the incidence of ischaemic 
heart disease but this does not apply to the 
incidence/ 
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incidence of atherosclerotic lesions of the 
coronary arteries. 
It would seem reasonable to conclude 
from both these observations that some aetio- 
logical factors influence the development or 
ischaemic heart disease without producing any 
marked change in the incidence of coronary 
atherosclerosis. It might be suggested that 
thrombosis is such a factor but at present tnere 
is no convincing evidence that coronary throm- 
bosis is on the increase, and there is little 
doubt that thrombosis can become incorporated 
into the arterial wall; thus any increase in 
the incidence or thrombosis would probably be 
reflected by an increase in atheroma as well. 
Myocardial infarction rarely occurs spontaneously 
in any species other than the human and cannot 
be produced experimentally without traumatic 
obstruction of a coronary artery. Yet áthero= 
sclerosis occurs spontaneously in a number of 
species, sucn as the rabbit and fowl, and can be 
produced experimentally in others by a variety 
of constraints, of which cholesterol feeding is 
almost always one: the extent and degree of 
these/ 
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these atherosclerotic lesions are more or less 
directly proportional to the hypercholesterolaemia 
which is induced. Although in animals myocard- 
ial infarction and fibrosis do not occur and 
atheroma of the coronary arteries is often 
histologically different from the human lesion, 
information gained from animal investigations 
should be studied in the human. Since cholest- 
erol feeding is almost always necessary in order 
to produce coronary atherosclerosis in animals, 
cholesterol metabolism and particularly the 
circulating cholesterol require, close examin- 
ation in relation to coronary atherosclerosis 
and ischaemic heart disease in the human. 
45. 
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Before any consideration of the circul- 
ating lipids in relation to coronary disease, 
their nature and physiological levels will be 
summarised. 
A. THE CIRCULATING LIPIDS AND LIPOPROTEINS 
IN HEALTH. 
1. Definition of the circulating lipids. 
a. Neutral Fat. These are triglycerides of 
various saturated and unsaturated fatty acids 
containing even numbers of carbon atoms. 
Chylomicrons (Gage and Fish, 1924) are aggregates 
of neutral fat molecules, which are visible in 
plasma since they measure approximately 1 micron 
in diameter, and are largely derived from chyle; 
they can be used as a measure of fat absorption. 
b. Fatty Acids. Neutral fats, esterified 
cholesterol and the compound lipids all contain 
fatty acids. Fatty acids also circulate in a 
chemically "free" form although physically bound 
to certain proteins. 
i. Non -essential fatty acids are mostly 
saturated and are synthesised from "active acetate" 
derived from fat, protein and carbohydrate; 
examples are palmitic (016) and stearic acid (C18).ß 
ii. Essential fatty acids are unsaturated 
an 
47. 
and are not synthesised by the body but must be 
obtained from the diet. They are principally 
linoleic, linolenic and arachidonic acids which 
contain 2, 3 & 4 double bonds respectively. Of 
the three main circulating lipids, neutral fat, 
cholesterol and phospholipids (lecithin), the 
fatty acids of cholesterol esters are the most 
unsaturated (iodine number = 158: Bloor et el, 
1938) and are probably largely of the essential 
category. 
c. Sterols. Cholesterol makes up between 
95% and 98% of the circulating sterols but there 
are also minute quantities of dehydrocholesterol 
and 7- dehydrocholesterol in circulation. 
Cholesterol occurs in the plasma in two forms: 
approximately 30% as "free" cholesterol, when 
the hydroxyl group is unesterified and therefore 
can be precipitated by digitonin, and approximate- 
ly 70% as ester cholesterol when it is esterified 
with unsaturated fatty acids. Normally circul- 
ating cholesterol is always bound to protein 
whether free or esterified. Sperry (1934 has 
indicated that the ratio of ester to total 
cholesterol is remarkably constant. 
d. Compound Lipids. Many of these contain 
phosphorus and all include fatty acids in their 
structure./ 
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structure. Phospholipids or phosphatides are 
usually classified into lecithins, cephalin and 
sphingomyelin. Lecithins contain the base 
choline and make up approximately 80% of the plas- 
ma phospholipids. 
2. Definition of the circulating lipoproteins. 
For many years the clarity of serum and 
plasma suggested that its lipid content is 
stabilised in solution by linkage to protein, and 
in 1929 Macheboeuf indicated the presence of 
lipid- protein complexes by his isolation from 
serum of a substance which contained a repro- 
ducible proportion of nitrogen and lipids. It 
is now generally believed that neutral fat, 
cholesterol (free and esterified forms) and 
phospholipids are transported in the circulation 
combined with one another and with protein in 
macromolecular complexes called lipoproteins. 
The properties and structure of the 
lipoproteins, and the enzyme systems involved in 
their interaction, have not yet been defined but 
they are known to differ in chemical constitution, 
in solubility, in molecular size and in iso- 
electric point. Cholesterol and phospholipids 
are associated with all the protein fractions but 
by/ 
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by far the greatest concentration is attached to 
the .(j and/31 globulin fractions (Blix et al, 
1941), and these two lipid -laden globulins are 
termed the r( and f3 lipoproteins. 
Zone electrophoresis (Wieland and Fischer, 
19h8), which is based on the different rates of 
migration of the protein fractions in a buffer 
in an electric field, permits isolation of each 
protein component of the serum; actual chemical 
analysis of the serum lipoproteins can be ob- 
tained by subsequent elution of cholesterol and 
phospholipids from the adsorbent which can be 
starch or more commonly filter -paper (Nikkilä, 
1953; Boyd, 1954). Low temperature ethanol 
fractionation separates lipoproteins according 
to their physicochemical properties (Russ et el, 
1951). The ultracentrifuge produces a force 
many thousand times that of gravity and large 
molecules, such as lipoproteins, are induced to 
undergo flotation or sedimentation according to 
the relative density of the molecules and the 
medium. The concentration of these lipoproteins 
can be determined during ultracentrifugation 
by a photographic procedure (Gofman et al, 1949; 
de Lalla & Gofman, 1954) ; in general, the low 
density/ 
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density lipoproteins correspond to the (3-lipo- 
proteins and the high density lipoproteins to 
the o(- lipoproteins. 
3. The cholesterol :phospholipid (C /P) ratio. 
The ratio of the circulating cholesterol 
to the circulating phospholipids is reasonably 
constant in health (Peters and Man, 1943a) and 
there is evidence to indicate that the phospho- 
lpids have a stabilising effect on the colloidal 
dispersion of cholesterol (Boyd, 193 7). The 
degree of visible lipaemia appears to be in- 
versely related to the lecithin content of the 
serum (Ahrens and Kunkel, 1949), and thus the 
translucency of the serum is dependent not only 
on the lipid- protein attachments but also on the 
ratio of cholesterol to phospholipid within the 
macromolecule; thus elevation of the C/P ratio 
is said to favour cholesterol deposition (Ladd 
et al, 1949). The average cholesterol:phospho- 
lipid ratio (C /P ratio) of whole plasma is 
approximately 0.80 in health (see Table V1) the 
C/P ratio of the /3-lipoproteins (low density 
lipoproteins) is approximately 1.25 and the C/P 
ratio of the e4- lipoproteins (high density lipo- 
proteins) is approximately 0.55. Thus it is 
apparent/ 
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apparent that the C/P ratio of whole plasma is 
derived from the C/P ratio of the two major 
groups of lipoproteins and is dependent on the 
ratio of one lipoprotein to the other. 
la.. Origin and fate of the circulating 
cholesterol. 
The plasma cholesterol is derived from 
an exogenous (dietary) and an endogenous 
(synthetic) source. Dietary cholesterol is 
absorbed, 70% in an esterified form and 30% in 
a "free" (or non -esterified) form, and contributes 
directly 6o the plasma cholesterol. Isotope 
techniques have shown that cholesterol is 
synthesised from acetate (Bloch & Rittenberg, 
1942) and that all twenty -seven carbon atoms are 
derived from acetate (Wuersch, et al, 1952; 
Cornforth, et al, 1953). Moreover, acetyl 
coenzyme A (active acetate) has been shown to be 
involved in cholesterol biosynthesis (Klein & 
Lipmarn 1953; Boyd, 1953) and is a common key 
intermediate in the metabolic pathways of carbo- 
hydrate, protein and fat. Thus, the three chief 
dietary elements, which are all sources of active 




All animal cells contain cholesterol and 
tissue slice techniques have shown that many 
tissues, with the notable exception of brain 
(Srere et e1, 1950), are capable of cholesterol 
biosynthesis. However, the liver is the only 
significant source of plasma cholesterol and 
there is evidence that in some species the testes, 
spleen, kidney, lung and adrenals, though possess- 
ing the mechanism for cholesterol biosynthesis, 
in fact withdraw and utilise cholesterol from the 
plasma under physiological conditions (Landon & 
Greenberg. 1954). Many major plasma constituents 
including glucose, albumin, fibrinogen and probably 
& globulins, are now known to originate en- 
tirely in the liver, and the plasma and liver can 
be regarded as different compartments of the same 
system (Gould, 1951); isotope techniques have 
indicated that there is a free interchange of 
cholesterol and of phospholipids between the 
plasma and the liver (Hahn and Hevesy, 1940; 
Gould et al, 1951). 
Liver cholesterol is excreted into the 
bile as cholesterol and bile salts (glycocholate), 
and intestinal cholesterol is partially re- absorbed; 
biliary excretion and intestinal re- absorption of 
cholesterol/ 
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cholesterol are important homeostatic mechan- 
isms for the maintenance of a constant level 
plasma cholesterol. The transference of plasma 
cholesterol to venous extrahepatic tissues, where 
the sterol sometimes may be modified into steroid 
hormones, is probably largely irreversible. 
5. Normal levels of the circulating lipids 
and lipoproteins and the influence of age 
and sex. 
In all the investigations to be reported 
the plasma total and free cholesterol, hence 
esterified cholesterol by difference, has been 
estimated by the Sperry- Schoenheimer digitonin 
precipitation procedure as modified by Sperry 
and Webb (1950); the error of this method has 
been ± 6%. The phosphorus content of a lipid 
extract of plasma has been determined by the 
molybdenum blue method of Allen (1940); the 
error of this method has been ± 5 %. The oC andr3 
lipoproteins of serum have been separated by a 
filter -paper zone electrophoresis micro- technique 
(Boyd, 1954) and followed by serial cholesterol 
estimations. It has been possible, therefore, 
to determine the precise quantity of cholesterol 
in mg% attached to the two major lipoprotein 
fractions, but for convenience the distribution 
of cholesterol between the oC and ¡3 lipoproteins 
has/ 
54. 
has often been expressed as a percentage of the 
total cholesterol - thus 30% on the o(- lipoprotein 
fraction and 70% on the f3- lipoprotein fraction, 
or an o(:/3 lipoprotein ratio of 30:70; the 
accuracy of this ratio has been 
± 
3%. The normal 
daily intake of food had no immediate effect on 
the plasma cholesterol and C/P ratio (Table IV) 
and thus blood samples have not been taken ex- 
clusively in the fasting state. There is a 
slight and inconstant variation in plasma 
cholesterol during the 24 hours of the day (Boyd, 
1935), but in most, if not in all, healthy 
persons the plasma cholesterol is maintained at 
each individual's constitutional level and large 
deviations do not ordinarily occur (Sperry, 1937). 
Table IV. The effect of ordinary meals on 
the circulating cholesterol and 
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The plasma cholesterol of newborn 
infants is low (Sperry, 19364 Boyd, 1936) but 
rises rapidly within the first ten days of life; 
analysis of the blood from the umbilical cord of 
5 male and 5 female infants is thown in Table V. 
From the age of one year there is no significant 
increase in plasma cholesterol until puberty 
(Kornerup, 1950; Adlersberg et al, 1956) and 
after puberty subsequent changes depend on sex. 
Table V. The mean circulating lipids and 
lipoproteins of 5 male and 5 female 
infants at birth (umbilical cord blood) 
Males Females 
Plasma cholesterol (mg;'7o) 55 56 
C/P ratio 0.48 0.51 
oC :/3 lipoprotein ratio 35:65 37:63 
b. Men. 
The circulating lipids have been studied 
in 200 men of all decades from puberty (Table VI) 
and the oC : ¡3 lipoprotein ratio has been deter- 













































































































































































































































































































































































































































































































































































































Table VII. The mean a< :/a lipoprotein ratio 
in 75 apparently healthy men. 




20 - 29 10 29 : 71 - 7.3 
30 - 39 lb 26 : 74 
± 
7.2 
1.o - 49 21 23 : 77 ± 6.8 
50 - 59 17 20 : 80 - 7.4 
60 - 69 8 19 : 81 - 
70 + 3 22 : 78 - 
The subjects of this study were healthy members 
of the University and hospital staffs or in- 
patients without evidence of cardiac, renal, 
hepatic or metabolic disease. The plasma 
cholesterol and C/P ratio increased from puberty 
until the age of 30 -35 years, but thereafter no 
further significant increase was observed (Oliver 
& Boyd, 19531. ). Most investigators agree 
that there is a gradual rise in plasma cholesterol 
with increasing age up until 35 years, but there- 
after the pattern is less clear. The results 
shown in Table VI indicate that the plasma 
cholesterol does not increase significantly in 
men :-ever 35 in Britain and confirm similar 
observations in the United States (Page et al, 
1935/ 
57. 
1935; Foldes and Murphy, 1946): recently these 
results have been confirmed by Adlersberg et al, 
1956 and Little et al, 1956. Other investigators 
have shown an increase in plasma cholesterol with 
increasing age (Melka, 1927; Keys, 1949; 
Gertler et al, 1950; Keys et al, 1950; Kornerup, 
1950; Russ et al, 1951). However, Keys et al 
(1950), who observed a steady progression with 
advancing age in a large series of Minnesotan 
bank clerks did not observe any rise in a group 
of Neapolitans (Keys et al, 1952), and suggested 
that the difference between the two studies might 
be related to the lower fat intake of the Italian 
Apparently inconsistent results may depend partly 
on racial and environmental influences (see 
section on race page 65) since many of these 
studies were conducted in different countries. 
At all events the rise in cholesterol is not 
very marked and probably not an obligatory con- 
comitant of ageing. 
c. Women. 
In view of the striking sex difference 
in the incidence of clinical coronary disease 
(Page 37), and the relative immunity from 
coronary disease enjoyed by premenopausal women, 
58. 
a special study of the circulating lipids and 
lipoproteins was made in relation to the two 
physiological activities which occur in women 
during their reproductive years - the menstrual 
cycle and pregnancy. 
i. The Menstrual Cycle. 
There have been very few studies of 
the circulating lipids in relation to the menstrual 
cycle and none in which blood samples have been 
obtained at frequent intervals throughout the 
cycle. Elevation of the plasma cholesterol 
immediately before menstruation was reported by 
Gonalons (1916), by Moynihan (1925) and by Okey 
and Boyden (1927) who also observed a rise after 
menstruation. 
The plasma cholesterol and C/P ratio 
were determined in 12 young healthy women, of 
whom one was amrried and all were nulliparous, 
and also in 12 young healthy men; these subjects 
were students, secretaries or laboratory technic- 
ians. The mean age of the female group was 22 
years and the mean age of the male group was 21 
years. 
The subjects were instructed in the use 
of/ 
59. 
of a clinical thermometer, and asked to record 
their waking oral temperature every morning 
while still lying in bed. Ovulation was taken 
as occurring at or just before the point where 
the temperature begins to rise during the 
intermenstrual phase (Rubenstein, 1937 ). Blood 
samples were taken in the fasting state twice 
weekly over 5 weeks. It was particularly im- 
portant to eliminate possible day to day varia- 
tions in the quantitative analyses, which were 
therefore performed by making a lipid extract 
of the plasma immediately after the sample was 
taken and storing this extract in a sealed glass 
ampoule in a cool, dark box. When ten samples 
had been obtained from each individual, all the 
estimations were made on the same day. 
Definite cyclical changes were observed 
in all 12 women (Fig. 8) (Oliver & Boyd, 1953a). 
At ovulation there occurred a striking fall in 
plasma total cholesterol, due entirely to a fall 
in plasma ester cholesterol, with a rather less 
marked fall in plasma phospholipids and therefore 
a fall in the C/P ratio. Whereas in the 
follicular and luteal phases of the cycle there 
was a greater increase in plasma total cholesterol 
than/ 
Fig. 8. The mean changes in the circulating lipids 
of 12 healthy young women during the 
menstrual cycle. The changes in the 
plasma total and ester cholesterol and in 
the plasma phospholipide are shown as the 
percentage deviation from the mean of the 
entire cycle; the actual values of the 
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60. 
than in plasma phospholipids, and therefore a 
relative increase in the C/P ratio: Fig. 9 
shows the changes which occurred in a typical 
young woman. In contrast, there was no regular 
fluctuation in the circulating lipids in the 12 
young healthy men (Fig. 10). 
A further group of 12 normal young 
women were studied and it was found that the 
distribution of cholesterol between the oC : 3 
lipoprotein fractions also underwent regular 
cyclical change. Less cholesterol was attached 
to the/3-lipoprotein fraction, and thus there was 
a higher oC: /3 ratio at ovulation than at any time 
during the menstrual cycle (Fig. 11) (Oliver and 
Boyd, 1955c). 
ii. Pregnancy. 
The presence of hypercholesterolaemia 
during pregnancy was first suggested by Becquerel 
and Rodier in 18L.5 and first observed by Neumann 
and Hermann (1911) and by Chauffard et at, (1911). 
Early studies, which were all made at or just 
before term, resulted in discordant views on the 
behaviour of the circulating lipids in advanced 
pregnancy. Gardner and Gainsborough (1929), who 
were the first to study the lipids of pregnancy 
with/ 
Fig. 9. The changes in the circulating lipids of 































0 4 13 27 Cycle 
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Fig. 10. The mean changes in the circulating 
lipids of 12 healthy young men over a 
period of 35 days. The changes in the 
plasma total and ester cholesterol and 
in the plasma phospholipids are shown as 
the percentage deviation from the mean 
of the period of study; the actual 
values of the C/P ratio are given. 
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Fig. 11. The mean changes in the 10,(: 
!3 
lipoprotein 
ratio of 12 healthy young women during 
the menstrual cycle. The high ratio 
at ovulation is due both to an increase 
in 04- lipoprotein cholesterol and a 
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61. 
with the digitonin precipitation procedure, 
did not consider that there was any consistent 
elevation of plasma total cholesterol; and 
Boyd (1934) , who reviewed these early studies, 
considered that the discrepancies were largely 
a function of the medium analysed (whole blood, 
red cells, serum or plasma) and concluded that the 
most important change was a twofold increase in 
neutral fat but that there was no significant 
elevation of total cholesterol. During the 
last 20 years there have been few studies of the 
circulating lipids in pregnancy and the puerperium 
and the belief that hypercholesterolaemia prevails 
in pregnancy has not been firmly established. 
The majority of investigators have studied the 
last few weeks of pregnancy or have made their 
determinations on pooled blood or on different 
groups of women at each month. 
The subjects studied were 12 normal 
primigravidae between the ages of 18 and 31 years, 
mean age 2L years. The women, 13 in number, were 
selected from the Antenatal Clinic of the Royal 
Simpson Memorial Maternity Pavilion; one was 
subsequently discarded from the study on account 
of abortion at the 12th week of her pregnancy. 
The conditions for the selection were that the 
women/ 
62. 
women should be primigravid, less than 12 weeks 
pregnant, anticipating confinement in hospital 
and obstetrically and medically healthy. All 
12 women attended at two -weekly intervals from 
the 9th week until confinement. Blood samples 
were taken at the same time of day every 2 weeks 
and the patient was instructed to avoid food or 
fluid during the preceding 3 hours. A blood 
also 
sample was /taken during labour, within 12 hours 
of birth, on the 3rd, 7th and 14th post -partum 
days, and 6, 12, and 20 weeks after delivery; 
the last four samples were not taken at any 
regular time in the day but when the mother found 
it most convenient to leave her baby. 
At no time can an exact relationship 
be assumed between the supposed week of pregnancy 
and the actual stage of gestation which has been 
reached; it was therefore considered, when 
assembling the results, more accurate to start 
calculation of the mean values from a defined 
point, such as birth, than from a supposed one, 
such as the 9th week. The mean number of days 
between the specimen taken during labour and the 
preceding specimen was 8 and thus this latter 
sample was regarded as representative of the 
39th week, and for each earlier sample 2 weeks 
were/ 
63. 
were deducted. Two of the women were a little 
uncertain of the date of the first day of their 
last menstrual period, but it is likely that this 
variable has been obviated by assuming the 
gestation period to be 40 weeks and calculating 
the mean values in retrograde manner as described. 
The babies weighed between 6 lbs. 1 oz. and 8 lbs. 
12 oz. and there were no obvious signs of pre- or 
post -maturity. 
Hypercholesterolaemia developed in all 
12 women and was maximal during the third 
trimester (Fig. 12) (Oliver and Boyd, 1955a). 
Between the 7th and 8th months the mean plasma 
total cholesterol was elevated by 50% (P<(0.01); 
ester cholesterol also rose by 50% and free 
cholesterol by 59 %. The mean plasma total 
cholesterol fell before labour and nearly reached 
the initial level by the 4th postpartum month 
(P((0.01). The plasma phospholipids and the 
C/P ratio increased by 25% (P<0.01) by the 7th 
and 8th months of pregnancy (Fig. 12) , and 
subsequently fell at labour. The ratio of 
cholesterol between the e< and l3 lipoprotein 
fractions also rose significantly (P.<0.02) by 
the 8th month (Fig. 13). By the 20th post- partum 
week/ 
Fig. 12. The mean changes in the circulating 
cholesterol and the C/P ratio of 12 
healthy young primigravidae during 
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Fig. 13. The mean changes in the circulating 
lipoprotein cholesterol of 12 healthy 
young primigravidae during pregnancy 
and the puerperium. 
(The serum is applied to the filter 
paper at the point represented by the 
vertical line and is induced to migrate 
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CHOLESTEROL ATTACHED TO THE /3 AND d LIPOPROTEINS 
BEFORE, DURING , AND AFTER PREGNANCY, AS DETERMINED 
BY FILTER PAPER ELECTROPHORESIS. 
64. 
week, when all but one of the women had ceased 
lactation and all had had at least one menstrual 
period, none of these mean values had quite 
returned to the levels observed during the first 
trimester. These slightly higher levels are 
not statistically significant for this small group, 
and no attempt was made to relate them to any 
particular phase of the first post -partum menstrual 
cycle. The mean increase in weight of the 12 
women during pregnancy was 36 ± 8 lb. and by the 
20th post -partum week it had fallen by 25 ± 6 lb; 
thus the mean weight of the women was 9 lb. greater 
5 months after the pregnancy than it was before 
the pregnancy. There was no correlation between 
the weights during the post- partum period and the 
levels of the circulating lipids. Eight boys 
and 4 girls were born to the 12 women and there 
was no relationship between the degree of hyper - 
cholesterolaemia in the mother and the sex or the 
birth weight of the child. 
iii. Post -menopausal years. 
The circulating lipids have been studied 
in 75 women from the age of 40 (Table "VIII); 
the subjects were miscellaneous patients who had 

























































































































































































































































































































































































































































disease. No significant difference was observed 
between the W-49, , 60 -69 and over 70 age groups, 
but the plasma cholesterol and C/P ratio of the 
50 -59 age group was significantly higher than 
the other decades (Oliver & Boyd, 1953b). This 
unexpected observation has recently been confirmed 
by Adlersberg 11 al (1956). Explanation of this 
rise in the plasma lipids in the first post- 
menopausal decade and of the subsequent fall in 
later decades is not readily forthcoming, but might 
be related to the hormonal changes associated 
with the menopause and the withdrawal of 
oestrogens at that time (Page 97). These in- 
fluences of age and sex and the normal cholest- 
erol pattern in the human are shown diagram- 
matically in Fig. 1/4 . 
6. The influence of race. 
It is difficult to dissociate the effect 
of primary racial genetic characteristics from 
environmental habits, which could be responsible 
for most of the racial differences in the cir- 
culating lipids and lipoproteins. The economic 
status and standard of living, and the social 
and religious habits of various races differ 
widely; these environment factors determine the 
quantity/ 
Fig. 1L1. A diagrammatic representation of the 
influence of age and sex oh the circ- 
ulating cholesterol in health. The 
unbroken line represents males and the 
broken line represents females; P 
indicates the level of the plasma 
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quantity and quality of the diet, and so 
influence the circulating cholesterol levels very 
considerably. Elaborate epdemiological studies 
have indicated that there exists a direct relation- 
ship between an increase in dietary fat and 
standard of living with an increase in circulating 
cholesterol (Keys and Anderson, 195)4; Keys et al, 
1955; Bronte -Stewart et al, 1955). 
7. The influence of diet. 
a. Dietary cholesterol. 
The circulating cholesterol in men is 
largely independent of dietary cholesterol. 
Ingestion of excess cholesterol produces only 
slight and transient elevation of plasma cholest- 
erol (Collen et al, 1949; Keys, 1949) , although 
very large quantities of cholesterol will cause a 
greater increase in circulating cholesterol 
(Messinger et al, 1950). Reduction of dietary 
cholesterol does not produce any significant 
decrease in plasma cholesterol (Keys et al, 1950). 
b. Dietary fát. 
Diets rich in fat, but not necessarily 
in cholesterol, are associated with high levels 
of circulating cholesterol (Widal et al, 1913; 
Keys et al, 1955). In most civilised countries 
more/ 
67. 
more than one -third of the total caloric intake 
is derived from fat and the average cholesterol 
levels are higher in these countries than in 
more primitive communities. Reduction of total 
dietary fat will lower circulating cholesterol 
(Ivellinkoff et al, 1950) and a rice -fruit diet, 
devoid of cholesterol and fat, produces a 
substantial fall (Kempner, 19L4.8). 
Until recently animal (saturated) and 
vegetable (unsaturated) fats were regarded as 
interchangeable so far as their effect on the 
circulating lipids and lipoproteins was concerned 
(Hildreth ét al, 1950) , but now there is 
accumulating evidence to indicate that the 
physiological levels may be dependent in part on 
the relative, if not on the absolute, intake of 
essential or unsaturated fatty acids. Nutrition- 
al studies on vegetarians compared with non - 
vegetarians have indicated that high plasma 
cholesterol levels are closely associated with 
the intake of saturated fatty acids and lack of 
unsaturated fatty acids (Hardinge and Stare, 
195L4), The addition of unsaturated vegetable 
oils to the diet reduces the level of plasma 
cholesterol/ 
68. 
cholesterol (Kinsell et al, 1952, 1953) and lack 
of unsaturated fatty acids appears to result in 
elevation of the plasma cholesterol (Kinsell et 
al, 1956). However, complete starvation 
causes mobilisation of fat reserves, lipaemia, 
increase in the circulating cholesterol, the 
C/P ratio (Kartin et al, 19141) and an increase in 
low density lipoproteins (Rubin and Aladjem, 195+) 
B. THE CIRCULATING LIPIDS AND LIPOPROTEINS IN 
PATIENTS WITH ISCHAET+.IC HEART DISEASE. 
Evidence has been presented earlier that 
there are large amounts of cholesterol in athero- 
sclerotic arterial lesions and that this lipid is 
largely, if not entirely, derived from the plasma. 
Conditions where there is elevation of the cir- 
culating cholesterol are associated with a high 
incidence of atherosclerosis and ischaemic heart 
disease (see Page 41). It would seem desirable, 
therefore, to determine whether there is any 
abnormality in the circulating lipids and lipo- 
proteins in patients who have developed the 
clinical manifestations of coronary atherosclerosis 
1. Plasma cholesterol and C/P ratio. 
Three studies in the United States have 
suggested that there is elevation of the plasma 
cholesterol and probably of the C/P ratio in 
patients/ 
69. 
patients with ischaemic heart disease (Morrison 
et el, 1948; Gertler et al, 1950; Steiner et al, 
1952). A larger study (Oliver and Boyd, 1953b) 
precisely controlled in respect of age and sex, 
was undertaken in order to determine the relation- 
ship between cholesterol and ischaemic heart 
disease in Britain where the dietary habits differ 
slightly from those in the United States. 
The subjects were 200 consecutive 
admissions with ischaemic heart disease and 200 
miscellaneous controls. In the coronary disease 
group, there was electrocardiographic confirmation 
of myocardial infarction in 170, and of ischaemia 
before or after the Master two -step test in 30 who 
presented clinically with angina of effort; 
any subject who lacked electrocardiographic 
confirmation of ischaemic heart disease was ex- 
cluded. Adequate controls were very difficult to 
obtain from a hospital population, but were care- 
fully selected members of the medical and scien- 
tific staff, and from convalescent inpatients, 
who had no history or clinical features of cardiac, 
renal, hepatic or metabolic diseases. The 
coronary disease group was completed first, and 
the mean age of each decade of both sexes was 
determined;/ 
70. 
determined; the control group was then completed 
so that the mean age and number of cases in each 
decade corresponded with the coronary disease 
group. Blood samples taken during anticoagulant 
therapy or within five weeks of the occurrence 
of myocardial infarction have been excluded from 
the study. All subjects received a light ward 
or weight- reducing diet. 
The levels of the plasma lipids of each 
group have been contrasted by decades and ex- 
pressed separately for the sexes; the mean levels 
and standard errors are shown in Figs. 15 - 18. 
Fig. 15 shows the mean plasma cholesterol and 
Fig. 16 the mean plasma C/P ratio in the men, 
and Table IXa shows the actual values of these 
means together with the standard deviations and 
ranges. There was significant elevation of the 
plasma cholesterol and the C/P ratio in men with 
coronary disease in all decades and the maximum 
elevation occurred between the ages of 30 and 39. 
Fig. 17 represents the mean plasma cholesterol 
and Fig. 18 the mean C/P ratio in the women, 
and Table IXb shows the actual values of these 
means together with the standard deviations and 
ranges. As for men, there was significant 
overall/ 
Fig. 1 5 The mean plasma cholesterol levels in 
149 consecutive male admissions for 
ischaemic heart disease and in a 
matched control group; the number 
of cases in each group for each decade 












DECADES 30 -39 
NUMBER 







40 50 60 70+ 
-49 -59 -69 
36 52 37 12 
Fig. 16. The mean plasma C/P ratio in 149 
consecutive male admissions for ischaemic 
heart disease and in a matched control 
group; the number of cases in each 
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Fig. 17. The mean plasma cholesterol levels in 
51 consecutive female admissions for 
ischaemic heart disease and in a matched 
control group; the number of cases in 
each group for each decade is also shown. 
PLASMA FEMALES 
TOTAL CHOLESTEROL 











30 50 6:0 
-49 -59 -69 








Fig. 18. The mean plasma C/P ratio in 149 
consecutive female admissions for 
ischaemic heart disease and in a matched 
control group; the number of cases in 






































































































































































































































































































































































































































































































































































































































































































































































overall elevation of these values in women with 
coronary disease in all decades except the sixth 
when the values of the control group and coronary 
disease group were identical (see Page 65). 
In women, there was no hypercholesterolaemia in 
the earliest decade of the study. 
Whereas there was significant elevation 
of plasma cholesterol and the C/P ratio in the 
coronary disease group, there was also considerab 
overlap in the levels of the two groups. Thus, 
in 19% of the apparently healthy men either the 
plasma cholesterol was above 205 mg% or the C/P 
ratio was greater than 0.94 (these figures are the 
mean values + one standard deviation), and in 
4% either the plasma cholesterol was above 239 mg% 
or the C/P ratio was greather than 1.07 (these 
figures are the mean values + two standard 
deviations). Similarly, 29% of the men with 
coronary disease had either plasma cholesterol 
levels lower than 205 mg% or C/P ratio levels 
less than 0.94. However, only 154 of the 48 men 
with ischaemic heart disease under the age of 50 
demonstrated either a low plasma cholesterol or 
a low C/P ratio. The overlap between the control 
and coronary groups is further reduced when 
lipoprotein analysis are included, and under the 
age/ 
72. 
age of 50 only between 5 and 9,'3 of patients with 
ischaemic heart disease had entirely normal 
levels (see Page 79). The most significant eL 
tion in the plasma cholesterol and C/P ratio 
occurred in men who had developed ischaemic 
heart disease under the age of 40 (see Page 77). A 
marked degree of hypercholesterolaemia may favour 
the premature development of ischaemic heart 
disease, and exposure to a high plasma cholesterol 
for a short period may have the same deleterious 
effect on the coronary arteries that might result 
from milder and more long -standing elevation. 
2. Serum lipoproteins. 
a. In the human. 
The circulating lipids do not exist free 
in plasma but are attached to protein; these 
lipids are almost entirely bound to the of and ¡3 
globulins and these lipid -protein macromolecules 
are termed the aC and 
f3 
lipoproteins (see Page 48). 
It would seem desirable to determine the dis- 
tribution of cholesterol between these two lipid 
carriers in patients with heart disease and other 
conditions associated with hypercholesterolaemia. 
The subjects (who were different from those 
reported on the preceding pages) were 50 consecutive 
men,/ 
73. 
men with ischaemic heart disease under the age 
of 50, 50 miscellaneous controls, 4 men and 4 
women with xanthoma tuberosum, 3 men and 1 woman 
with xanthoma tendinosum, and 2 men with 
"essential hyperlipaemia ". The control group, 
which was matched by age to the coronary group, 
consisted of members of the medical and scien- 
tific staff and convalescent inpatients, who had 
no history of clinical features of cardiac, renal, 
hepatic or metatolic disease. In the coronary 
disease group, there was electrocardiographic 
confirmation of myocardial infarction in 39 and 
of ischaemia before or after the Master two -step 
test in 11 who presented clinically with angina 
of effort; these men were not receiving any 
therapy at the time of the estimation and none 
had had a myocardial infarct within three months 
of the determinations, which were repeated on all 
the subjects on several occasions. 
The lipoprotein pattern in the coronary 
disease group and xanthoma group is contrasted 
with the normal pattern in Fig. 19. The results 
expressed in Table X indicate that the concen- 
tration of cholesterol attached to the ¡3 -lipo- 
protein fraction is increased in the coronary 
disease/ 
Fig. 19. The circulating lipoprotein cholesterol 
in healthy men, in men with ischaemic 
heart disease and in 12 patients with 
xanthomatosis. 
(The serum is applied to the filter 
paper at the point represented by the 
vertical line and is induced to migrate 









CHOLESTEROL ATTACHED TO THE ¡3 ANDo(LIPOPROTEINS AS 





















































































































































































































































































































































































































































































































































































































































disease group when contrasted with the control 
group, and the concentration of cholesterol 
attached to the a(-lipoprotein fraction is 
correspondingly decreased (Oliver and Boyd, 1955b); 
this study has been extended to a larger, but 
uncontrolled, group of patients with ischaemic 
heart disease under 50 (see Page 77 and Table XII ). 
The men with coronary disease were all comparative- 
ly young (mean age 41) and thus the majority 
exhibited hypercholesterolaemia (see Pages 70 & 77). 
It is probable that the rather greater increase 
in the )(3 -lipoprotein cholesterol in the present 
investigation when compared with studies of older 
men with ischaemic heart disease (Nikkilä, 1953; 
Rosenberg et al, 1954) is largely due to this 
hypercholesterolaemia, and that, whereas the 
group can fairly be regarded as representative 
of the young coronary population, it is probably 
not a cross section of the older coronary 
population in which marked hypercholesterolaemia 
is rather less frequent. 
b. Species differences in relation to 
atherosclerosis. 
There are marked and interesting 
differences between the species in the dis- 
tribution of cholesterol between the serum 
lipoproteins/ 
75. 
lipoproteins in relation to the development of 
atherosclerosis (Table XI)(Boyd and Oliver, 1956); 
and, although not directly related to the in- 
vestigation of patients with ischaemic heart 
disease, this comparative study indicates a 
positive correlation between an increasing con- 
centration of ß -lipoprotein cholesterol and the 
tendency to develop atherosclerosis. In the rat 
it is difficult to increase the plasma cholesterol 
by feeding cholesterol or fat, and until recently 
this species was regarded as immune from atheroma; 
however, it has now been shown that exposure to 
cold (1 - 3 °C) for 12 months results in hyper - 
cholesterolaemia and the development of typical 
atherosclerotic lesions in the intima of the 
aorta (Sellers and You, 1956). In the rat the 
percentage distribution of cholesterol between 
the a: and¡3 lipoproteins is approximately 90 :10. 
By contrast the corresponding percentage dis- 
tribution in normal dog plasma is 70:30, and 
typical atherosclerotic lesions can readily be 
induced by cholesterol feeding provided thyroid 
activity is depressed at the same time (Steiner 
& Kendall, 19.6). In the normal rabbit the 













































































































































































































































































































































































































































































































































































the a( and /3 lipoproteins is 50:50, and athero- 
sclerotic lesions can easily be induced by 
moderate cholesterol feeding. Birds most closely 
resemble the human in that atherosclerosis may 
develop spontaneously (Dauber. 191i)í) and the 
of :(3 lipoprotein ratio is approximately 40:60. 
In the human, virtually every adult shows some 
degree of atheroma in the aorta and there is 
therefore no strict normal group for study; 
comparisonsof patients and "normals" are actually 
comparisonsbetween different degrees of severity 
of atherosclerotic lesions. However, the so.::/3 
lipoprotein ratio in a group of healthy men was 
28:72 (see Table X) in contrast to 10:90 in men 
with established coronary disease (Oliver & Boyd, 
,1955b). 
3. The circulating lipids and lipoproteins 
in young patients with ischaemic heart 
disease and their significance. 
The presence of marked abnormality of 
the circulating lipids and lipoproteins in young 
patients with ischaemic heart disease is further 
emphasised by the study of 237 such patients, who 
were referred to the Department of Cardiology in 
the Edinburgh Royal Infirmary during the last 5 
years. These patients all had electrocardio- 
graphic/ 
77. 
graphic evidence of myocardial infarction or 
ischaemia, and the results of their lipid and 
lipoprotein analysis are shown in Table XII. 
Table XII. The mean circulating lipids and 
lipoproteins in patients with 
ischaemic heart disease under the 
age of 50. 
MALES FEMALES 
40 40 -49 40 40 -49 
























Number of cases 32 36 13 15. 
o(: (3 lipo- 
protein ratio 
SIE 
8 :92 8:92 11 :89 14:861 
The standard deviation of the /N-lipoprotein 
cholesterol, when expressed in mgo, represents 
a change of = 5% in the a(:/5 lipoprotein ratio. 
tThe standard deviation of the /3-lipoprotein 
cholesterol, when expressed in mg6/, represents 
a change of 8% in the 04:/S lipoprotein ratio. 
In 140 healthy subjects of both sexes 
under the age of 50 the mean plasma cholesterol 
was/ 
78. 
was 182 ± 38 mg and the mean C/P ratio was 
0.81 
± 
0.13, and in 76 similar subjects the mean 
d::(3 lipoprotein ratio was 22 :78 
± 
7. These 
subjects were carefully selected members of the 
medical and scientific staff, and convalescent 
inpatients who had no history or clinical features 
of cardiac, renal, hepatic or metabolic diseases; 
their lipid and lipoprotein analyses have been 
used as controls in some of the studies already 
mentioned. The addition of one standard deviation 
to these means increases the plasma cholesterol 
level to 220 mt, the C/P ratio to 0.94 and the 
of :, lipoprotein ratio to 15 :85. Regarding 
these levels as the upper limits of "normal ", 
the percentage of apparently healthy young adults 
and the percentage of young patients with isch- 
aemic heart disease with "normal" circulating 
lipids and lipoproteins have been assessed and the 
results are shown in Table XIII. 
Table XIII./ 
79. 
Table XIII. The percentage of apparently healthy 
young adults and the percentage of 
young patients with ischaemic heart 
disease with "normal" circulating 




40 years 40 -49 years 
Coronary 
Group 








221 m 91% 11% 87% 26% 
C/P ratio 
below 0.95 87% 30% 83% 38% 
Plasma cholest- 
erol below 
221 mg% + C/P 
ratio below 0.95 93% 9% 91% 20% 
Number of cases 44 45 32 51 
040 lipo- 
protein ratio 
below 16 :84 94% 20% 88% 19J 
Plasma cholest- 
erol below 
221 m + C/P 
ratio below 0.95 
+ 0(0 lipo- 
protein ratio 
below 16:84 96% 90% 9% 
Any/ 
80. 
Any attempt to divide the control group 
from the coronary disease group on the basis of 
their circulating lipids and lipoproteins depends 
on the arbitary choice of certain values to 
represent the upper limits of normality. Several 
possibilities were investigated but the division 
based on the addition of one standard deviation 
to the mean values of the control group resulted 
in the most significant separation of the groups. 
This separation is quite impressive under the 
age of 40 when only about 5% of each group do not 
conform to the majority; the division of the 
groups is not so complete between the ages of 40 
and 49 and becomes even less with advancing age - 
for instance, between 60 and 69 years 44% of the 
coronary group were found to have normal levels 
of both the plasma cholesterol and the C/P ratio, 
although only 10% of the control group had abnormal 
levels. 
When preventitive treatment for ischaemic 
heart disease becomes available, it will be 
necessary to develop methods for screening the 
apparently healthy population in order to discover 
those who will later develop the disease. It is 
likely/ 
81. 
likely that analyses of the circulating lipids 
and lipoproteins will contribute greatly to such 
an investigation of the healthy population. It 
is suggested, moreover, that these analyses are 
useful and reasonably reliable adjuvants to the 
diagnosis of coronary disease in young patients. 
4. Heparin clearing reaction. 
Post- prandial plasma turbidity or lipaemia 
normally disappears following the intravenous 
administration of heparin (Hahn, 194.3); this 
action of heparin can only be initiated in vivo. 
Block et al (1951) reported that a small intra- 
venous injection of heparin produced less clearing 
of lipaemic plasma in 27 males with myocardial 
infarction or with atherosclerotic obliteration 
of the lower limb vessels when compared with 23 
normal men of a slightly younger age group. 
They suggested that there may be a relationship 
between atherosclerosis and the lack of dis- 
appearance of alimentary lipaemia following heparin 
It was thought that this observation merited 
further investigation. 
One hundred subjects were studied. With 
the exception of a few ill patients, 50 were 
consecutive admissions with electrocardiographic 
confirmation,/ 
82. 
confirmation of myocardial infarction or 
ischaemia, and 50 were miscellaneous hospital 
inpatients without evidence of cardiac, hepatic, 
renal or metabolic diseases. The subjects 
received for breakfast 100 g. of fat in the form 
of L?.O% cream and developed a consistent post- 
prandial lipaemia. The turbidity of the plasma 
was measured by determining its optical density 
(on a Unicam Absorptiometer) before, 3 hours after 
and 3.:1 hours after the fat meal. A small intra- 
venous injection (300 I. U.) of heparin was given 
at the height of the postprandial lipaemia 3 hours 
after the fat meal. 
Heparin induced less clearing of the 
lipaemia in the coronary disease group than in 
the control group (Table XIV) (Oliver and Boyd, 
1953c). In Fig. 20 the average optical density 
of each group has been diagrammatically superimposed 
on the normal absorption curve following the inges- 
tion of 100 g. of fat. Thus, at 3 hours the 
change in the translucency of lipaemic plasma res- 
ulting from the heparin injection can be contraste 
with the level of lipaemia before heparin was ad- 
ministered. The course of normal lipaemia was 








































































































































































































































































































































































































































































































































































































































































Fig. 20. A diagrammatic representation of the 
clearing of alimentary lipaemia induced 
by the intravenous injection of 300 I. U. 
of heparin in patients with ischaemic 
heart disease and in a comparable control 
group. 











O i r i 
I 2 3 1/4 4 
TIME IN HOURS 
83. 
developed usually about 3 hours after the fat 
meal and disappeared 3 hours later. There is, 
therefore, no reason to believe that there might 
be any sudden spontaneous change in the degree 
of lipaemia between 3 and 3. hours after a fat 
meal. There was slight overlap of individual 
values for percentage clearing from the coronary 
disease group into the range of the control group, 
and conversely; thus the application of heparin 
clearing of lipaemic plasma as an adjuvant to 
the diagnosis of coronary artery disease is limit- 
ed, perhaps by the difficulty of excluding athero- 
sclerosis in the control group. Additional 
studies concerning the nature and speed of the 
clearing action of heparin have been described 
(Oliver & Boyd, 1953c) but do not come directly 
into the theme of this thesis. 
Explanation of the difference between 
the coronary disease and control groups in the 
clearing of alimentary lipaemia by a small in- 
jection of heparin is not readily forthcoming. 
Exogenous heparin apparently requires some tissue 
component in addition to plasma in order to 
produce a clearing factor. Although heparin has 
not been detected in normal plasma, there is con- 
siderable/ 
84. 
siderable evidence that a heparin -like sulphated 
mucopolysaccharide is present in mast cells, and 
the physiological dissolution of chylomicra may 
depend upon the presence of an endogenous heparin - 
induced clearing factor. The postprandial lipae- 
mia in old age and in subjects with atherosclero- 
sis is of longer duration than in the normal, and 
this suggests that less endogenous clearing factor 
may be available in the presence of atherosclero- 
sis. In this connection there is some histo- 
logical evidence to suggest that extracellular 
cholesterol depositions occur at areas containing 
heparin -like sulphuric acid esters (Faber, 1949), 
and thus atherosclerotic 'changes might restrict 
the availability of an endogenous heparin -like 
substance and thereby reduce the concentration 
of circulating clearing factor. 
C. CONCLUSION. 
There is no doubt that the plasma 
cholesterol, the C/P ratio and the concentration 
of cholesterol on the (3 -lipoprotein fraction are 
all elevated in the majority of patients who have 
developed the clinical features of coronary athero- 
sclerosis. These abnormalities are most marked 
in patients who develop symptoms under the age of 
50/ 
85. 
50 and particularly under the age of 4o. A small 
percentage of patients do not exhibit any abnor- 
mality in the analysis of the circulating lipids 
and lipoproteins and therefore such analyses cannot 
be used as diagnostic tests for the presence of 
impending ischaemic heart disease; however, they 
havproved to be a useful adjuvant towards the 
solution of an equivocal clinical diagnosis 
particularly in young subjects. In patients with 
ischaemic heart disease, in contrast to healthy 
men and women, a more prolonged lipaemia develops 
after a meal rich in fat, and the clearing of 
this lipaemia by heparin is less efficient and 
quick. Whereas this difference is obvious and 
significant, it is not entirely consistent and 
also cannot be used as a diagnostic test for the 
presence of impending ischaemic heart disease. 
These results leave little doubt that 
ischaemic heart disease is frequently associated 
with some disturbance of the circulating lipids 
and lipoproteins. Moreover, a recent elaborate 
L year cooperative survey has shown conclusively 
that the circulating lipids and lipoproteins are 
abnormal before the development of any of the 
clinical features of coronary atherosclerosis. 
(Report/ 
86. 
(Report of a cooperative study of the lipoproteins 
and atherosclerosis, 1956). This association 
of abnormal circulating lipids and lipoproteins 
with coronary atherosclerosis, together with the 
patchy distribution of atherosclerotic lesions, 
the high incidence of ischaemic heart disease in 
early middle age, its prevalence in males and 
the influence of heredity and body build, all 
indicate that coronary atherosclerosis is not 
solely an inevitable result of advancing years. 
It would seem reasonable to postulate that 
coronary atherosclerosis is an active process and 
is dependent, at least to some extent, on a 
disturbance of lipid metabolism. 
Four possible explanations for this 
association of coronary atherosclerosis with a 
disturbance of lipid metabolism will now be 
examined: 
1. It might be a chance association. This 
possibility can be dismissed with considerable 
confidence in view of the unanimity of several 
different investigators that such an association 
exists, and the statistical significance of 
their results. 
2. It might result from a primary change 
within the wall of the coronary arteries, or from 
a/ 
87. 
a primary disturbance of the physiological 
mechanisms which normally prevent the deposition 
of fibrin or formation of thrombi. 
Resolution of the inflammatory process, 
formation of fibrous and hyaline material and 
degenerative changes in tissues are often 
associated with accumulation of cholesterol esters. 
Whereas such changes may account for some of the 
cholesterol in the wall of coronary arteries, the 
quantity of lipid that accumulates in athero- 
sclerotic lesions is so large as to preclude the 
possibility that it all originates from the simple 
breakdown of intimai tissue (Duff & McMillan, 1951). 
Furthermore, it is doubtful whether cholesterol 
is synthesised in any quantity, or even at all, 
in the arterial wall (Gould, 1951). It is 
likely, if any primary change takes place in the 
arterial wall, that the site of this change will 
act as a nidus for cholesterol deposition rather 
than a stimulus to local synthesis of cholesterol. 
It is difficult to visualise how a primary 
disturbance of the physiological coagulation - 
fibrinolysis balance could result in hypercholest- 
erolaemia, unless a change in the concentration 
er 
of the various accejlators, decelerators and 
cofactors,/ 
88. 
cofactors, which maintain the blood in its fluid 
state, alter S. hepatic cholesterol biosynthesis 
at the same time. It seems improbable that 
deposition of fibrin or formation of a thrombus 
in an artery could upset the biosynthesis of 
cholesterol in the liver, unless fibrin is ini- 
tially deposited in the hepatic rather than the 
coronary arteries and aorta, but there is no 
evidence that this is so. 
3. It might contribute directly towards the 
development of coronary atherosclerosis. This 
as been and is still widely believed. Hyper - 
holesterolaemia of some degree is nearly always 
essential for the production of atherosclerotic 
lesions in animals, and the extent and duration 
of the hypercholesterolaemia determines the 
umber and the severity of atherosclerotic lesions. 
ioreover, there is a great deal of evidence, review - 
-d by Hueper (19WWla) and brought up to date in the 
ection on arterial lesions (see Page l2 ), that 
lasma cholesterol passes physiologically through 
he vessel wall from the lumen and contributes 
to, or may be entirely responsible for, the 
cholesterol in the atherosclerotic plaque. The 
patchy/ 
89. 
patchy distribution of atherosclerotic lesions 
in the coronary vascular tree indicates that some 
parts are more prone to cholesterol deposition 
than others and, since the composition of the 
plasma which bathes the vascular lining is 
essentially the same in all areas, this discrete 
distribution of atherosclerotic lesions probably 
depends on local differences in the arterial wall 
or on local haemodynamic effects. The nature and 
relative importance of various local factors have 
not been thoroughly investigated, but variations 
in intimai permeability and in the metabolic 
activities of the intimai cellular elements in 
handling lipids presented to them may be important 
(Duff & McMillan, 1951) . Certainly it is true 
that anoxaemia or damage to the arterial wall 
predisposes to cholesterol deposition and the 
development of atherosclerotic lesions (Hueper, 
1944, 1945). Hypercholesterolaemia and in- 
stability of the cholesterol.protein attachment 
probably result in the accumulation of cholesterol 
in the intima but are certainly not the sole 
causes of such deposition; local and haemodynamic 
factors may be of equal importance. 
4./ 
90. 
L4.. Abnormal metabolism of lipids and 
atherosclerotic lesions in the coronary arteries 
might both be secondary to some other alteration 
of physiological function. It is possible that 
the abnormalities in the circulating lipids and 
lipoproteins, the thrombotic tendency and the 
atherosclerotic lesions in coronary arteries 
all have a common denominator. This postulate 
will now be examined (see Part III) and a hypo- 
thesis will be developed that an alteration of 
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A. THE INFLUENCE OF ThE ENDOCRINE GLANDS 
AND ADMINISTERED HORMONES ON THE CIRCULATING 
LIPIDS AND LIPOPROTEINS. 
1. The circulating lipids and lipoproteins in 
relation to certain physiological endocrine 
changes. 
a. Menstrual cycle. 
Depression of the plasma cholesterol, the 
C/P ratio and the ¡3 -lipoprotein cholesterol with 
elevation of the o&- lipoprotein cholesterol 
occurred regularly at ovulation and during 
menstruation of 24 young healthy women; and 
the opposite changes in the circulating lipids and 
lipoproteins developed during the luteal phase 
of the cycle (see Page 58 & Figs. 8, 9 and 11). 
The secretion of oestrogens also undergoes 
regular cyclical variation and is generally 
believed to be maximal immediately before ovul- 
ation (Smith & Smith, 1936; Brown, 1955) and to 
remain high throughout the luteal phase, and some 
workers have observed a secondary peak just before 
menstruation, (Gustayson et al, 1938). Progest- 
erone secretion, as measured by urinary preg- 
nanediol excretion, increases after ovulation to 
reach a peak at about the 22nd day of a 28 day 
cycle and thereafter gradually falls (Yenning & 
Brown, 1937). It seems reasonable, therefore, to 
correlate the cyclical changes in the circulating 
lipids and lipoproteins with the regular varia- 
tions in these sex hormones; it is suggested that 
toe/ 
93. 
the decrease observed in the former at ovulation 
could result from the increased endogenous 
secretion of oestrogens and that the opposite 
changes observed during the luteal phase might 
possibly be related to the endogenous secretion 
of progestins. However, since there is some 
retention of sodium chloride and water at the 
time of ovulation and particularly just before 
menstruation (Thorn et al, 1938), the possibility 
cannot be entirely excluded that the observed 
cyclical changes may be partly the result of 
dilution of the plasma, even although there were 
no regular changes in the plasma proteins in 
this series of 2L. women. 
b. Pregnancy,. 
Elevation of the plasma cholesterol, the 
C/P ratio and the ¡3 -lipoprotein cholesterol 
with depression of the o& -lipoprotein cholesterol 
has been observed during pregnancy in 12 young 
healthy primigravidae (see Page 60 and Figs. 12 
and 13). This hypercholesterolaemia in late 
pregnancy has been variously ascribed to de- 
creased elimination of cholesterol in the bile, 
to increased adrenal synthesis of cholesterol, 
to placental toxins, to the influence of the 
foetus and to the metabolic requirements of 
lactation, but the evidence to implicate any of 
these/ 
94.. 
these factors is circumstantial and unconvincing. 
Endocrine influences have also been suggested 
as a cause of the hypercholesterolaemia (Schiller, 
1919; Boyd, 1934) and certainly in pregnancy 
there are considerable changes from the normal 
endocrine balance. 
The behaviour of the circulating lipids 
and lipoproteins during pregnancy must be con- 
sidered in relation to some of these endocrine 
changes. The concentration of oestrogens, 
estimated by semiquantitative measurements of 
urinary oestrogens, rises steadily during preg- 
nancy until the last month when there is probably 
no further increase, and at term there is a sharp 
drop (Yenning, 194.6). This increase in the 
urinary concentration of oestrogens (which pre- 
sumably reflects the concentration of circulating 
oestrogens) is in the region of a thousandfold, 
and its occurrence in association with elevation 
of the circulating lipids and lipoproteins is at 
variance with the suggestion that the endogenous 
secretion of oestrogens may cause depression of 
these values at ovulation (see Page 92) and with 
the observation that the administration of 
oestrogen/ 
95. 
oestrogen preparations results in depression of 
the circulating lipids and lipoproteins (see Page 
119). It is possible that this lipid -depressant 
action of oestrogens is antagonised during preg- 
nancy, or that the concentration or relative 
proportions of the various oestrogens are such 
that the depressant action is lost. The concen- 
tration of circulating progesterone, as judged 
by urinary pregnanediol excretion, is increased 
twentyfold (yenning, 1946), but administered 
progesterone does not cause any very striking 
elevation of the circulating lipids and lipo- 
proteins (see Page 122). While androgens un- 
doubtedly elevate these values (see Page 122) 
there is no evidence that androgens are secreted 
in excess by pregnant women, and furthermore, 
the 17- ketosteroid excretion is not increased 
(yenning, 1946). 
In pregnancy there is elevation of the 
serum protein -bound iodine (Heinemann et al, 1948), 
increased radio -active iodine uptake (Pochin, 1952), 
and during the last 4 months elevation of the basal 
metabolic rate (Javert, 1940). The hypercholest- 
erolaemia of pregnancy seems anomalous in the 
presence of these signs of increased thyrotrophic 
and/ 
96. 
and thyroid activity, which usually result in 
depression of the circulating lipids and lipo- 
proteins (see Page 106). Adrenocortical activity, 
as megsured by determination of the blood and 
urinary 17- hydroxycorticoids, is also increased 
during pregnancy (Yenning, 1946; Gemzell, 1953), 
yet the administration of adrenocorticotrophic 
hormone and cortisone cause depression of the 
circulating lipids and lipoproteins (see Page 109). 
The development of hypercholesterolaemia 
in the presence of increased oestrogenic, thyroid, 
and adrenocnrtical- activity is unexpected and at 
present unexplained. There is evidence that the 
secretion of growth hormone from the hyperplastic 
anterior pituitary is, in common with the secretion 
of the other trophic.hormones, increased during 
pregnancy (Young, 1951). Moreover, increased 
secretion of growth hormone may be partly res- 
ponsible for the increased insulin requirement 
of the diabetic pregnant woman and the birth of 
large babies from prediabetic and diabetic mothers 
(Young, 1953). It is possible that more complete 
nderstanding of the intavelationship of growth 
ormone, glucagon and insulin may help to explain 




Elevation of the plasma cholesterol and 
C/P ratio has been observed during the first 
postmenopausal decade (Fig. 14 and Table VIII). 
This might be related to the decrease in oestro- 
gradual 
genic activity and also to any /postmenopausal 
decrease in thyroid or adrenocortical activity. 
If there is a hormonal basis for the postmeno- 
pausal rise in healthy women, it does not appear 
to influence hypercholesterolaemic subjects in 
the same way since no postmenopausal rise was 
observed in women with established ischaemic heart 
disease (Figs. 17 and 18). Explanation of the 
subsequent fall in the circulating lipids is 
not readily forthcoming; this fall has recently 
been confirmed by Adlersberg et al (1956), who 
observed the postmenopausal rise only between the 
ages of 53 and 57. 
2. Incidence of coronary disease in certain 
endocrine disorders. 
a. Diabetes mellitus. 
The occurence of coronary disease in a 
diabetic patient was first reported in 1864 by 
Seegen; subsequently it has been indicated that 
coronary/ 
98. 
coronary atherosclerosis and ischaemic heart 
disease are common in diabetic patients (Joslin, 
1930; Blotner, 1930). Advanced and often 
occlusive atherosclerosis of the coronary arteries 
has been demonstrated at autopsy in 53% of 973 
diabetic patients in contrast to 28% of 5829 non - 
diabetic patients of comparable age; and similarly, 
coronary thrombosis was observed at autopsy in 
32% of 790 diabetic patients and in 16% of 5650 
nondiabetic patients of comparable age (Liebow and 
Hillerstein, 1949). Thus coronary disease is 
twice as common in diabetic than in nondiabetic 
subjects. Provided they have the disease long 
enough, diabetics will almost invariably become 
atherosclerotic; of 484 autopsies on patients 
who had had diabetes for 5 or more years, only 4 
were free from atherosclerosis (Warren, 1938). 
Diabetes also hastens the development of coronary 
atherosclerosis and ischaemic heart disease in 
youth (Joslin and Wilson, 1950) and eliminates the 
relative immunity of women (Clawson & Bell, 1949). 
b. Myxoedema. 
In 1888 a Report by the Committee of the 
Clinical Society of London described atheromatous 
changes in the arteries of only 5 out of 84 cases 
of myxoedema, but since then there have been fre- 
quent reports/ 
99. 
reports of a high incidence of coronary athero- 
sclerosis in association with myxoedema (Black 
and Kampmeier, 1934; Bruger and Rosenkrantz, 
1942; Means, 1948). However, the existence of 
this association is not universally accepted, and 
Andrus (1953) does not believe that there is 
any conclusive evidence that gross atherosclerosis 
is an inevitable consequence of hypothyroidism. 
Myxoedema has its highest incidence at ages when 
atherosclerosis is mat common, and it is often 
difficult therefore to assess the influence that 
myxoedema may have had on the development of 
coronary atherosclerosis. The report of the 1888 
Committee is often quoted against any correlation 
between myxoedema and atherosclerosis, but it 
should be noted that the occurrence of ather o- 
sclerosis.in only 6% of the cases is much less tha 
would be expected in autopsies of non -myxoedematou 
adult subjects (White et al, 1950), and the mecho . 
of assessment of atherosclerotic lesions were not 
very comprehensive. However, the observation of 
a high incidence of atherosclerosis in patients 
with endemic cretinism and goitre (Wegelin, 1925) , 
and in young patients with thyroid deficiency 
(Fishberg, 1924; Hoelzer, 1940) offers more 
substantial/ 
100. 
substantial support for a relation between the 
two conditions. 
The incidence of ischaemic heart disease 
may not be increased in untreated myxoedema 
(Means, 1948). Although it is probable that 
myxoedema favours the development of coronary 
atherosclerosis, the function of these diseased 
arteries may be quite adequate for the demands 
of the myocardium when metabolism is retarded. 
As soon as metabolism is increased by the 
administration of a thyroid derivative, the 
atherosclerotic coronary arteries become relativel 
inadequate and angina develops; and there is no 
doubt that the development of angina in treated 
myxoedematous patients is common (Means, 1948). 
Like diabetes, myxoedema may diminish the sex 
difference in the incidence of ischaemic heart 
disease; in a group of 59 cases of spontaneous 
myxoedema, ischaemic heart disease occurred as 
frequently in women under 50 as in men under 50 
(Bartels & Bell, 1939). Endocrine disorders 
occurred in 30% of women who developed ischaemic 
heart disease under the age of 40 (Table XV). 
Table XV./ 
101. 
Table XV. An analysis of the health of 20 women 
who developed ischaemic heart disease 
before the age of 40. 
Associated disease or disorder Number of patien 
Endocrine disorders: 
Myx oe dema 
Menopause aged 32 




During pregnancy or puerperium 
Anaemia 










c. peradrenocorticism (Cushing's Disease). 
Atherosclerosis was observed in 3 out of 
9 autopsied cases originally described by Cushing 
(1932), and extensive calcification was apparent 
radiologically in the aorta of his first case; 
all 4 were under the age of 28 years. Generalise 
vascular sclerosis has been reported in 6 patients 
who died from Cushing's disease or hyperadreno- 
corticism, and cholesterol deposits have been 
observed in the endothelium of small arteries 
(Heinbecker, 1944); 5 of these 6 patients died 
under the age of 33 years. Subsequently, the 
statement that atherosclerosis, especially of the 
coronary/ 
102. 
coronary arteries, occurs with increased frequency 
in Cushing's disease has often been made without 
detailed evidence to support this contention 
(Williams, 1951; Wakerlin, 1952; Katz & Stamler, 
1953) ; however, Thompson and Eisenhardt (1943) 
reported 98 cases, of whom 63 had an autopsy, 
without mention of atherosclerosis. Cushing's 
disease is associated very fregeuntly with 
hypertension and diabetes and often with depressio 
of thyroid function, and any premature development 
or increase in the incidence of atherosclerosis 
may well be related to these other influences. 
The suggestion that atherosclerosis develops 
earlier and to a greater degree in Cushing's 
disease is not well documented or controlled, 
and the evidence that it results from hyperadreno- 
corticism is largely circumstantial. 
d. Castration. 
Examination of the hearts of 49 women, in 
whom bilateral ovariectomy was performed between 
the ages of 2 and 42 years, revealed more severe 
coronary atherosclerosis, decade for decade, than 
the average degree of coronary atherosclerosis 
of a control group CNuest et al, 1953); yet only 
3/ 
103. 
3 of these 49 patients were found to have had 
clinical manifestations of coronary disease. No 
other comparable investigation has yet been re- 
ported and no studies of the hearts of male 
castrates have been recorded. 
3. The circulating lipids and lipoproteins in 
certain endocrine disorders. 
a. Diabetes mellitus. 
There is little doubt that the frequency 
and severity of atherosclerosis in diabetes can 
be correlated with the duration of uncontrolled 
glycosuria and hyperglycaemia and with the con- 
comitant hyperlipaemia and hypercholesterolaemia 
(Joslin et al, 19L4.6). Hyperlipaemia is more 
marked than hypercholesterolaemia (Hirsch et al, 
1953), yet of a series of 273 diabetic patients 
50% exhibited elevated circulating lipids while 
92% of those with severe atherosclerosis showed 
hyperlipaemia (Pomeranze and Kunkel, 1950). 
Hypercholesterolaemia was often observed in young 
diabetics (Rabinowitch, 1935). Ultracentrifuge 
studies in diabetics have shown abnormally high 
concentrations of the particular cholesterol-con - 
taining lipoproteins (Sf 12 -20 class) which are 
associated with atherosclerosis (Gorman et al, 
1950). Thep-lipoprotein cholesterol is higher in 
diabetics with atherosclerosis / 
104. 
atherosclerosis than in diabetics without athero- 
sclerosis, and higher in the latter group than 
in nondiabetics (Baker et al, 1955). Nearly 
all the diabetic patients seen in the Department 
of Cardiology had co- existent vascular disease, 
and no comprehensive analysis has been made in 
diabetics without vascular disease; however, 
Table XVI demonstrates the degree of abnormality 
of the circulating lipids and lipoproteins in a 
man of 19, in whom diabetes presented by the 
development of diffuse eruptive cutaneous xanthoma . 
Table XVI. The circulating lipids in a 19 year o 1 
man with xanthoma diabeticorum. 





















Diabetes is, therefore, associated with 
abnormal circulating lipids and lipoproteins and 
a parallel relationship exists between hyper - 
lipaemia and hyperglycaemia (Hirsch et al, 1953). 
These/ 
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These abnormalities of the circulating lipids and 
lipoproteins are probably a direct consequence 
of insulin lack, but they may also depend partly 
on the degree of renal damage associated with 
intercapillary glomerulo- sclerosis; tubular 
insufficiency and proteinuria in nephrosis is 
associated with both hyperlipaemia and hyper - 
cholesterolaemia (Peters & Man, 1943c). 
b. Myxoedemá. 
It is well known that myxoedema is 
associated with hypercholesterolaemia (Mason et al, 
1930; Hurxthal, 1934; Gildea et al, 1939). This 
increase in circulating cholesterol is not due sole 
ly to lowered metabolism, since dinitro -O- cresol 
will restore metabolism to normal without reducing 
the hypercholesterolaemia associated with hypo- 
thyroidism (Dodds & Robertson, 1933) and reduction 
in metabolism in euthyroid subjects is not 
accompanied by hypercholesterolaemia (Mason et ál, 
1930). In myxoedema the concentration of 
cholesterol on the /5-lipoprotein fraction is 
elevated (Malmros & Swahn, 1953), and ultra- 
centrifuge studies have indicated that the con- 
centration of the potentially atherogenic 
(Sf 12 -20) class of lipoproteins is also increased 




It is well established that the circulatin 
cholesterol is low when there is hyperfunction of 
the thyroid (Epstein & Lande, 1922; Mason et al, 
1930; Peters & Man, 1943). The plasma cholester- 
ol is generally lowest in patients with very 
marked hyperthyroidism, but there is no absolute 
direct correlation with the height of the basal 
metabolic rate. 
d. Hyperadrenocorticism Cushing's ,Disease). 
Analyses of the circulating lipids in 
hyperadrenocorticism have not been reported 
frequently. The blood cholesterol was reported 
in 5 of Cushing's cases and was elevateu in one 
(Cushing, 1932); there appears to be no consis- 
tent abnormality, although there is occasionally 
hypercholesterolaemia (Heinbecker, 1944; 
Heinbecker & Pfeiffenberger, 1950) but hyper - 
cholesterolaemia has also been reported in 
Addison's disease (Medvei, 1935). Peters and 
Van Slyke (1946) believe that any hypercholesterol 
aemia, which may occur in association with hyper - 
adrenocorticism, can be explained by accompanying 
diabetes and renal damage. Thus, there is no 
convincing evidence that Cushing's disease is 
associated with hypercholesterolaemia or with an 
increased incidence of atherosclerosis and 




No study of the circulating lipids and 
lipoproteins has mock yet been reported after 
gonadectomy, but in 2 out of 3 patients, in whom 
bilateral ovariectomy had been carried out, there 
was elevation of the circulating lipids and 
lipoproteins (Table XVII); angina occurred in 
1 woman at the age of 38 and a myocardial infarct 
developed in another at the age of 49. In the 
third patient, there was auricular fibrillation 
and mild thyrotoxicosis, which might account 
for the normal circulating lipid levels. 
Table XVII. The circulating lipids and lipo- 









































L4.. The influence of hormones on the circulating 
lipids and lipoproteins. 
The effect of extraneous influences on the 
circulating cholesterol, such as a dietary con- 
straint or the administration of hormones, may be 
delayed for several days. The "half- life" of the 
circulating cholesterol is 8 days (London and 
Rittenberg, 1950) , and thus any change in the 
circulating cholesterol or the concentration of 
cholesterol on the f3 -lipoprotein fraction re- 
sulting from an alteration in the rate of bio- 
synthesis or degradation will be delayed. However, 
when there is a redistribution of cholesterol 
between the cells and extracellular fluid (such 
as may occur after the administration of certain 
thyroxine analogues), the effect on the circulating 
cholesterol could be apparent within a day or two. 
In general the subjects of these investi- 
gations were either healthy men, or hypercholest- 
erolaemic men with ischaemic heart disease and 
electrocardiographic evidence of a myocardial 
infarct. It was not considered justifiable to 
administer hormones with a pronounced metabolic 
effect, such as ACTH, cortisone and the sex 
hormones, to healthy subjects. 
a./ 
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a. Pituitary hormones. 
i. Adrenocorticotrophic hormone. 
The daily intramuscular administration of 
50 mg. adrenocorticotrophic hormone (ACTH) for 8 
days resulted in significant depression of the 
plasma cholesterol, the C/P ratio and the /3 -lipo- 
protein cholesterol with elevation of the QC-lipo- 
protein cholesterol in 6 hypercholesterolaemic men 
with proven coronary disease (Table XVIII). The 
daily administration of 100 mgm. of ACTH for 5 days 
resulted in similar changes in the circulating 
lipids and lipoproteins in a further 6 hyper - 
cholesterolaemic men with proven coronary disease 
(Fig. 21 and Table XVIII) (Oliver & Boyd, 1955c, 
1956b). These results confirm the experiences 
of Conn et al, (1950) in 3 normal men but appear 
to contradict the observations of Adlersberg 
dt al, (1950, 1951); this apparent discrepancy 
will be considered later (see section concerning 
cortisone on page 111). 
ii. Thyroid stimulating hormone. 
The daily intramuscular administration 
of 10 units of thyroid stimulating hormone (TSH) 
for L. days did not cause any significant change 
in the circulating lipids and lipoproteins in 
3 subjects with primary myxoedema (Table XVIII) 
























































































































































































































































































































































































































































































































































































































































Fig. 21. The changes in the circulating lipids 
and lipoproteins during the intramusc- 
ular administration of 100 mg of ACTH 
daily to 6 hypercholesterolaemic men 
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The intramuscular administration of the same dose 
of TSH for L. days to 3 hypercholesterolaemic men 
with coronary disease resulted in significant 
depression of the circulating lipids and lipo- 
proteins (Table XVIII). These results suggest 
that TSH has no direct action on the circulating 
lipids and lipoproteins, and that any effect 
in euthyroid subjects is mediated through 
stimulation of functioning thyroid tissue. 
iii. Growth hormone. 
The intravenous infusion over a period 
of 30 minutes of 180 ml. of normal saline con- 
taining 200 mg. of a porcine growth hormone 
(STH) prepartion did not result in any immediate 
or delayed change in the cteulating lipids and 
lipoproteins in 3 healthy men (Table XVIII). 
This same growth hormone preparation was known 
to be effective in rats in stimulating hepatic 
cholesterol biosynthesis after inhibition by 
hypophysectomy. It is unlikely, therefore, that 
the preparation was metabolically inert, although 
it is possible that the dose was too small to 
produce any effect on the circulating lipids and 
lipoproteins; this may be so, but it has been 
shown that a similar dose resulted in a fall in 
blood/ 
blood aminoacid nitrogen and hyperglycaemia 
(Carballeira et al, 1952). It is possible that 
prolonged intramuscular administration of a crys- 
talline growth hormone preparation (not widely 
available) or of a human growth hormone prepara- 
tion might influence the circulating lipids and 
lipoproteins, although in general the metabolic 
activity of growth hormone preparations is dis- 
appointing at present. 
iv. Gonadotrophic hormones 
Preparations of gonadotrophic hormones, 
whether predominantly follicular -stimulating or 
luteinising, have not been administered in man 
with the object of assessing their influence on 
the circulating lipids and lipoproteins. Animal 
assays have indicated that these preparations 
do not have eithr a purely follicular -stimulatin 
or a purely luteinising action, and thus it was 
considered that study of the influence of the 
individual sex hormones on the circulating lipids 
and lipoproteins would be of greater value. 
b. Adrenal cortical hormones 
i. Cortisone 
The daily oral administration of 100 mg. 
of/ 
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of cortisone acetate for 10 days resulted in 
significant depression of the plasma cholesterol, 
the C/P ratio and the p-lipoprotein cholesterol 
with elevation of the oC -lipoprotein cholesterol 
in 6 hypercholesterolaemic men with proven 
coronary disease (Fig. 22 and Table XIX). The 
daily administration of 150 mg. and of 200 mg. 
of cortisone acetate each for 10 days resulted 
in similar changes in the circulating lipids and 
lipoproteins in two further groups of 6 hyper - 
cholesterolaemic men with proven coronary 
disease (Table XIX)Oliver and Boyd, 1955e, 1956b) 
The influence of cortisone acetate on 
the circulating lipids and lipoproteins is, 
thrfore, similar to that of ACTH. These results 
in hypercholesterolaemic subjects, all of whom 
were at work and reasonably healthy, do not 
necessarily contradict those of Adlersberg et al 
(1950, 1951), who showed that ACTH and cortisone 
raised the serum cholesterol in patients who were 
severely ill with diffuse lupus erythematosis, 
polyarteritis nodosa, dematomyositis and other 
collagen diseases. In their cases the sympto- 
matic improvement, the reduction of fever, and 
the/ 
Fig. 22. The changes in the circulating lipids 
and lipoproteins during the oral admin- 
istration of 100 mg of cortisone acetate 
daily to 6 hypercholesterolaemic men 























































































































































































































































































































































































































































































































































































the return of appetite probably contributed to 
the rise in circulating cholesterol; moreover, 
in the few of their patients who were hyper - 
cholesterolaemic and who had some disease other 
than a collagen disorder, the plasma cholesterol 
was not significantly raised by ACTH and cortison=. 
Mann and White (1953) considered that any eleva- 
tion of the plasma cholesterol produced by ACTH 
and cortisone could be due to relief of the 
acutely stressful phase of the disease in these 
very ill patients, thus permitting the low 
cholesterol levels to return to normal; certain- 
ly in Adlersberg's cases the initial levels of 
circulating cholesterol were unusually low in 
contrast to the values obtained in healthy 
American adults. 
The response of the circulating lipids 
and lipoproteins to ACTH and cortisone in the 
30 men referred to in Tables XVIII and XIX was 
remarkably uniform, and it is believed that, 
although these men were initially hypercholest- 
erolaemic, depression of these values may be the 
true reponse to ACTH and cortisone. 
ii. Desoxycorticosterone acetate./ 
115. 
ii. Desoxycorticosterone acetate. 
Although desoxycorticosterone acetate 
(Dom) is probably not a natural secretion of the 
adrenal cortex, it has been included in this 
section on the assumption that its effect on the 
circulating lipids and lipoproteins will represent 
the effect of naturally- occurring mineralocorti- 
coids. The daily intramuscular administration of 
5 mg. of desoxycorticosterone acetate for 5 days 
resulted in slight depression of the plasma 
cholesterol, the C/P ratio and the /3-lipoprotein 
cholesterol with increase in the oC- lipoprotein 
cholesterol in 6 hypercholesterolaemic men with 
proven coronary disease (Table XIX); the packed 
cell volume was reduced by 6. 
c. Thyroid hormones 
It has been known for many years that 
thyroid extract lowers the plasma cholesterol 
and phospholipids in hypothyroid and in euthyroid 
subjects, and at the same time increases their 
metabolic requirements (Lévy & Lévy, 1931; 
Turner & Steiner, 1939; Gildea et el, 1939); 
and more recently it has been shown that thyroxine 
also reduces the /3 -lipoproteins (Maimros & Swahn, 
1953) and/ 
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and lowers the concentration of the "atherogenic 
group" of low density lipoproteins (Sf 12 -20) 
as determined by the ultracentrifuge (Strisower 
et al, 1954) . The principle hormones secreted 
by the thyroid are thyroxine and triiodothyronine, 
which is derived from thyroxine by deiodination 
and probably has similar physiological actions. 
i. e -thyroxine sodium. 
I pothyroid subjects. The daily oral 
administration of 300 /g. of e- thyroxine sodium 
for 8 weeks resulted in sigrrtricant depression 
of the plasma cholesterol, C/P ratio and the /3 - 
lipoprotein cholesterol with elevation of c(- 
lipoprotein cholesterol in 6 patients with 
classical myxoedema (Fig. 23 and Table XX). 
The mean weight loss was 7 lbs. and the basal 
metabolic rate was increased by 17%. 
Euthyyroid subjects. The daily oral 
administration of 600jtg. of e- thyroxine sodium 
for 2 weeks resulted in similar changes in a 
further 6 euthyroid hypercholesterolaemic men 
with proven coronary disease (Fig. 21.E and Table 
XXI), except that the concentration of cholesterol 
on the o< -lipoprotein fraction also fell. 
The mean weight loss after 3 weeks was 14 lbs. and 
the basal metabolic rate increased by 13%. 
ii./ 
Fig. 23. The changes in the circulating lipids 
and lipoproteins, and in the basal meta- 
bolic rate and weight, during the oral 
administration of 300 Jug. of t -thyroxine 
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Fig. 24. The changes in the circulating lipids 
and lipoproteins and in weight during 
the oral administration of 6001.íg. of 
?-thyroxine sodium to 6 euthyroid hyper - 
cholesterolaemic men with ischaemic 
heart disease. 















































































































































































































































































































































































































































































































































































































































ii. ? -triiodothyronine. 
Hypothyroid subjects. The daily oral 
administration of 30µg. of i -triiodothyronine 
for 10 days resulted in depression of the plasma 
cholesterol, the C/P ratio and the / -lipoprotein 
cholesterol with elevation of the oC -lipoprotein 
cholesterol in 2 patients with classical myxoedema 
The mean weight loss was 6 lbs. and the basal 
metabolic rate increased by 15% (Table XX). 
Euthyroid subjects. The daily oral 
administration of 40),kg. of i- triiodothyronine 
for 5 weeks and then 60,ug. for 2 weeks to 3 
euthyroid hypercholesterolaemic men with proven 
coronary disease resulted in significant depressioi 
of the plasma cholesterol, the C/P ratio, and the 
/-lipoprotein cholesterol with elevation of the 
o(- lipoprotein cholesterol (Table XXI). There 
was no change in weight or in the basal metabolic 
rate. 
The daily oral administration of a larger 
dose (40,ug. for 2 weeks and then 100).4.g. for 
4 weeks) of -e- triiodothyronine resulted in 
similar changes in the circulating lipids and 
lipoproteins, except that the concentration of 
cholesterol/ 
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cholesterol on the 04(-lipoprotein fraction also 
fell, in a further 3 euthyroid hypercholesterol- 
aemic men with proven coronary disease (Fig. 25 
and Table XXI). The mean weight loss was 6 lbs. 
and the ba %al metabolic rate increased by lló. 
iii, Triiodothyroacetic acid. 
Triiodothyronine can undergo oxidative 
deamination to triiodothyropyruric acid with 
subsequent oxidative decarboxylation of the latter 
compound to triiodothyroacetic acid (triac); 
this acetic acid analogue of triiodothyronine 
was first synthesised by Pitt -Rivers (1953). 
Hypothyroid subjects. The daily oral 
administration of 0.5 mg. of triac for 21 days 
resulted in significant depression of the plasma 
cholesterol, the C/P ratio and /3 -lipoprotein 
cholesterol with elevation of the plasma cholest- 
erol in a 69 year old woman with classical 
myxoedema (Fig. 26 and Table XX) . There was no 
weight loss and no increase in the basal metabolic 
rate. The daily oral administration of a larger 
dose (L mg. for 6 days) of triac resulted in 
similar changes in the circulating lipids and 
lipoproteins in 2 patients with classical myxoedem 
(Fig. 27 and Table XX) . Within 24 hours there 
was/ 
Fig. 25. The changes in the circulating lipids 
and lipoproteins, and in the basal meta -I 
bolic rate and weight, during the oral 
administration of 40 and 100,,ug. of Q- 
triiodothyronine daily to 3 euthyroid 
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Fig. 26. The changes in the circulating lipids 
and lipoproteins, and in the basal meta- 
bolic rate and weight, during the oral 
administration of 500yg. of triiodo- 
thyroacetic acid daily to a 69 year old 
















































Fig. 27. The changes in the circulating lipids 
and lipoproteins, and in the basal meta- 
bolic rate and weight, during the oral 
administration of 4 mg of triiodothyro- 
acetic acid daily to 2 patients with 
myx o e dema. 
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was improvement of the clinical signs of 
myxoedema, weight loss and an increase in the 
basal metabolic rate. 
Euthyroid subjects. The daily oral 
administration of increasing doses (from 0.5 mg. 
to L. mg.) of triac over a period of 95 days re- 
sulted eventually in depression of the plasma 
cholesterol, the C/P ratio and the /3 -lipoprotein 
cholesterol with elevation of the d -lipoprotein 
cholesterol in 6 euthyroid hypercholesterolaemic 
men with proven coronary disease; there was no 
significant effect until 3 mg. of triac were 
administered daily (Fig. 28 and Table XXI). 
There was no weight loss, and the mean basal 
metabolic rate was not significantly altered 
although it was elevated in two of the men by 13% 
and 20% respectively. The action of some of 
these thyroid hormones has been described recently 
(Oliver & Boyd, 1957, Boyd and Oliver, 1957), and 
their potential therapeutic application will be 
considered later (see Page 153). 
d. Sex hormones 
i. Oestrogens 
The suggestion that depression of the 
circulating/ 
Fig. 28. The changes in the circulating lipids 
and lipoproteins, and in the basal meta- 
bolic rate and weight, during the oral 
administration of increasing doses of 
triiodothyroacetic acid daily to eu- 
thyroid hypercholesterolaemic men with 
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circulating cholesterol, the C/P ratio and 
/6-lipoprotein cholesterol at ovulation (see 
Page 92) might be due to endogenous secretion 
of oestrogens indicated that the influence of 
administered oestrogens on the circulating 
lipids and lipoproteins required assessment. 
(1) Ethinyl oestradiol. 
Pilot study. As the circulating lipids 
had not previously been studied after the 
administration of oestrogens, a small pilot study 
was necessary in order to determine the minimal 
dose required to alter these values. After a 
control period of 7 weeks, ethinyl oestradiol 
was administered orally to 3 hypercholesterol - 
aemic men with proven coronary disease and the 
dose was gradually increased over the next 10 
weeks from 0.02 mg. to 0.4 mg. daily. The mean 
plasma cholesterol remained constant up to a 
dose of 0.2 mg. of ethinyl oestradiol, but there- 
after decreased significantly (Fig. 29). This 
preliminary study suggested that the effective 
oral dose of ethinyl. oestradiol would not be 
less than 0.2 mg. daily. (Oliver and Boyd, 1954). 
Graduated study. The daily oral 
administration of increasing doses from 0.2 mg. 
to/ 
Fig. 29. The changes in the circulating lipids 
during a pilot study of the oral admin- 
istration of ethinyl oestradiol to 3 
hypercholesterolaemic men with ischaemic 
heart disease. 
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to 1 mg. of ethinyl oestradiol over a period of 
12 weeks to 15 hypercholesterolaemic men with 
proven coronary disease resulted in significant 
depression of the plasma cholesterol and C/P 
ratio (Fig. 30 and Table XXII). Ethinyl 
oestradiol and other oestrogens decrease the 
-lipoprotein cholesterol and increase the 
DC- lipoprotein cholesterol (Fig. 31). 
Large dose study. The daily oral 
administration of 1 mg. of ethinyl oestradiol 
for 6 weeks to 30 hypercholesterolaemic men with 
proven coronary disease resulted in similar chan 
in the circulating lipids and lipoproteins 
(Fig. 32 and Table XXII). 
Further experience concerning the 
administration of ethinyl oestradiol to hyper- 
cholesterolaemic men with coronary disease will 
be considered in the section concerning thera- 
peutic implications (see Page 158). 
(2). Hexoestrol & Stilboestrol. 
The daily oral administration of 60 mg. 
of hexoestrol for 14 days to 6 hypercholesterol - 
aemic men with proven coronary disease also 
resulted in significant depression of the plasma 
cholesterol/ 
Fig. 30. The changes in the circulating lipids 
during the oral administration of 
increasing doses of ethinyl oestradiol 
to 15 hypercholesterolaemic men with 











































































































































































































































































































































































































































































































































































































































































































































































































Fig. 31. The changes in the circulating lipo- 
protein cholesterol during the oral 
administration of ethinyl oestradiol 
to hypercholesterolaemic men with 
ischaemic heart disease. 
(The serum is applied to the filter 
paper at the point represented by the 
vertical line and is induced to migrate 









CHOLESTEROL ATTACHED TO THE/3AND d LIPOPROTEINS BEFORE 
AND DURING OESTROGEN THERAPY IN HYPERCHOLESTEROLAEMIC 
MALES WITH CORONARY SCLEROSIS AS DETERMINED BY FILTER 
PAPER ELECTROPHORESIS 
Fig. 32. The changes in the circulating lipids 
during the oral administration of 1 mg 
of ethinyl oestradiol daily to 30 hyper - 
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cholesterol, C/P ratio and A -lipoprotein 
cholesterol with elevation of the 0C-lipoprotein 
cholesterol (Table XXII); the administration of 
5 mg. of stilboestrol for Li_ weeks to 3 hyperchol- 
esterolaemic men with coronary disease produced 
comparàble results (Table XXII). 
(3) Naturally occurring oestrogens. 
The administration of oestradiol, oestron 
or oestriol to 15 hypercholesterolaemic men with 
coronary disease resulted in similar depression 
of the plasma cholesterol, the C/P ratio and the 
-lipoprotein cholesterol with elevation of the 
of -lipoprotein cholesterol (see Table XXII). 
ii. Progesterone 
The daily intramuscular administration 
of 100 mg. of progesterone for 5 days to 6 
hypercholesterolaemic men with proven coronary 
disease resulted in slight but probably insig- 
nificat elevation of the circulating lipids and 
lipoproteins (Table XXIII). 
Androgen 
The daily sublingual administration of 
50 mg. of methyl testosterone for 10 days to 


















































































































































































































































































































































































































































































































in elevation of the plasma cholesterol and 
lipoprotein cholesterol with depression of the 
o(- lipoprotein cholesterol (Fig. 33 and Table 
XXIII). This action of methyl testosterone was 
even more pronounced when administered immediately 
after a course of ethinyl oestradiol (Fig.43 and 
Table XXIII). 
The influence of some of these sex 
hormones on the circulating lipids and lipoproteins 
in men with ischaemic heart disease has been re- 
ported recently (Oliver and Boyd, 1956a, 1956b). 
e. Pancreatic hormones. 
i. Glucagon. 
The intravenous infusion of 2 mg. of 
glucagon ( "hyperglycaemic_:, factor of the pancreas ") 
over a period of 30 minutes to 3 healthy men re- 
sulted in immediate elevation of the blood 
glucose and 6 days later slight elevation of the 
plasma cholesterol and /6-lipoprotein cholesterol 
with depression of the o(- lipoprotein cholesterol 
(Fig. 34 and Table XXIV) (Oliver and Boyd, 1956b). 
ii. Insulin. 
The daily subcutaneous administration of 
50 units of insulin for a period of 5 weeks to 
6 men, who were suffering from depressive states 
(in Jordanburn Nerve Hospital), but were otherwise 
healthy, did not result in any significant change 
in the circulating lipids and lipoproteins. 
(Table XXIII)/ 
Fig. 33. The changes in the circulating lipids 
and lipoproteins during the oral admin- 
istration of 50 mg of methyl testosterone 
daily to 6 hypercholesterolaemic men 
with ischaemic heart disease. 
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Fig. 34. The changes in the plasma cholesterol 
and the blood glucose following the 
intravenous infusion of 2 mg. of glucagon 














































































































































































































































































































































































































































































(Table XXIII), although the induced hypo- 
glycaemia stimulated the patients to eat and 
they increased in weight by an average of 10 lbs. 
The daily subcutaneous administration of 
insulin to 6 hypercholesterolaemic diabetic 
patients resulted in snificant depression of 
the plasma cholesterol, the C/P ratio and /3 - 
lipoprotein cholesterol with an increase in a:- 
lipoprotein cholesterol; these changes occurred 
in parallel with the fall in blood sugar 
(Table XXIV). 
B. THE INFLUENCE OF HORMONES ON THE DEVELOPMENT 
OF CORONARY ATHEROSCLEROSIS AND ISCHAEMIC 
HEART DISEASE. 
In the belief that abnormal cholesterol 
metabolism, a thrombotic tendency and local 
haemodynamic disturbances in the arterial wall 
all favour the development of coronary athero- 
sclerosis and ischaemic heart disease, the 
influence of hormones on cholesterol metabolism, 
the fluid state of the blood and the arterial wall 
will now be considered. 
1. The influence of hormones on cholesterol 
metabolism. 
It has already been indicated that the 
sex/ 
125. 
sex hormones probably exert a physiological 
influence on the circulating lipids and lipo- 
proteins. It has also been emphasised that in 
patients with certain endocrine disorders, such 
as diabetes and myxoedema, there is an unsually 
high incidence of coronary atherosclerosis and 
clinical coronary disease. Furthermore, in 
patients with these same endocrine disorders, 
yet without any features of coronary disease, 
analysis of the circulating lipids and lipoprotein 
frequently reveals the abnormal patterns assoc- 
iated with overt ischaemic heart disease. The 
administration of certain hormones has resulted 
in alterations in the circulating lipids and 
lipoproteins, and these hormonal influences 
are summarised in Fig. 35. Administration of 
adrenal, thyroid and oestrogen preparations 
reduces the circulating cholesterol if it is high, 
and administration of androgens, and possibly 
also of glucagon and progesterone, raises the 
circulating cholesterol above normal levels. 
There is, then, little doubt that the endocrine 
glands and hormones can influence cholesterol 
metabolism. 
2./ 
Fig. 35. Summary of the actions of administered 
hormones on the circulating cholesterol. 
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2. The influence of hormones on the 
fluid state of the blood. 
a. Fibrinoenesis. 
The coagulation system may reasonably 
be regarded as consisting of two opposing groups 
of dynamic processes: those which favour the 
formation of thrombin and fibrin, such as Factors 
V and VII, calcium ions and other activators 
and accelerators; and those which prevail against 
the formation of thrombin and fibrin, such as 
heparin, antithromboplastin and other inhibitors, 
those 
or /which dispose of formed fibrin, such as the 
fibrinolytic system. Both these groups of 
processes can be influenced in vivo by hormones, 
although there is no evidence that the incidence 
of thrombosis is increased in endocrine disorders. 
Adrenaline and experimentally- induced 
stress accelerate clotting (Mills et al, 1928), 
increase prothrombin concentration (Uvnas, 1942; 
Leibetseder, 1951), and decrease heparin activity 
(Constantini and Tintori, 1951; Donzelot and 
Kaufmann, 1952). The administration of ACTH 
and cortisone during treatment of various 
collagen diseases has been associated with 
shortening of the clotting time and of the 
heparin -/ 
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heparin- retarded clotting time (Cosgriff et al, 
1950) , and an increase in the incidence of 
thromboembolic episodes in such patients (Cosgriff 
1951). In certain animals shortening of the 
bleeding time followed experimental stress ACTH 
and cortisone, yet similar stress failed to 
influence the bleeding time after hypophysectomy 
or after adrenalectomy (Ungar, 1945), these 
observations suggest that the pituitary and 
adrenal cortex can both influence bleeding time; 
however, in man cortisone shortens prolonged 
bleeding time (Jacobson, 1953). The clotting 
mechanism may be partly under neurogenic influence 
as adrenergic stimuli increase and cholinergie 
stimuli decrease the tendency to thrombosis 
(de Takats, 1944); it may be that post -operative 
thrombosis is an extreme example of this increase 
in haemostasis following stress. The admin- 
istration of growth hormone to dogs decreased 
the clotting time and prothrombin time (Campbell, 
1953). 
b. Fibrinolysis 
Indirect testing of the efficiency of the 
fibrinolytic system by the intravenous admin- 
istration of thrombin to rats suggested that ACTH 
and/ 
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and cortisone inhibit fibrinolytic activity, 
and that growth hormone, TSH, desoxycorticosterone 
acetate and testosterone increase fibrinolytic 
activity (Ungar, 1954). Stefanini and Damashek 
(1955) have confirmed that ACTH and cortisone 
decrease fibrinolysis, yet experimental stress 
and adrenaline increase fibrinolytic activity 
(L acfarlane & Biggs, 19)46; Biggs et al, 1947)- 
3. The influence of hormones on the arterial 
wall. 
Any agent which increases the hyperton- 
icity of arteries by producing contraction of 
the muscular elements in the arterial wall re- 
duces the vascular bed and necessitates a com- 
pensatory acceleration of blood flow and an 
increase in dynamic pressure. Moreover, pro- 
longed and inordinate vasoconstriction results 
in compression of the vasa vasorum by the con- 
tracting media with ischaemia of the arterial 
wall, particularly the inner layers, and the 
increased density of the contracted arterial wall 
may also hinder the normal diffusion of tissue 
fluids. Compression or active constriction of 
the capillaries within the arterial wall can 
result in local anoxaemia, which will alter 
the/ 
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the normal tissue metabolism and may act as an 
nidus for accumulation of fat and lead ultimately 
to an atheromatous lesion. 
a. Vasomotor tone. 
Prolonged arterial hypertonicity can lead 
to clinical hypertension, and the positive 
correlation between hypertension and coronary 
disease, particularly in women, is well known 
(Davis and Klainer, 19)40; Master, 1953). 
Certain hormones increase vasomotor tone and, 
although it is probable that the hypertension 
of Cushing's disease is largely related to the 
associated renal disease rather than the ex- 
cessive secretion of adrenal steroids, one of 
the secretions of the adrenal cortex probably 
has a definite vasopressor action. Desoxy- 
corticosterone can reasonably be regarded as a 
synthetic substitute for part of the adrenal cor- 
tical secretions, and experimentally it and the 
natural miner a locorticoid, 17- desoxocortisone, 
induce hypertension and hyaline changes in the 
arterial wall (Selye, 1950); however, aldosteron 
is said to lower vascular tone (Mach and Fabre, 
1955). In view of the vasodilating action of 
oestrogens,/ 
130. 
oestrogens, their withdrawal at the menopause 
has been implicated as a cause for the not 
uncommon development of hypertension and 
peripheral vascular insufficiency at the menopause 
(Scherf, 194.0). Adrenaline and noradrenaline 
cause elevation of the blood pressure through 
their powerful vasoconstricting action; vaso- 
constriction occurs in the renal, splanchnic and 
cerebral arteries, but vasodilation takes place 
in the coronary arteries. In 1903 Josué pro- 
duced degenerative lesions in the aortae of 
rabbits after repeated injections of adrenaline; 
many investigators have confirmed this observation 
and similar but more chronic arterial lesions, 
principally fibrous in character, develop in 
the coronary arteries as well as other arteries 
after the administration of small daily doses 
of adrenaline (Lange, l924). 
b. Capillaries. 
Whereas adrenaline increases vasomotor 
tone, arterial lesions may be partly due to 
constriction of the capillaries supplying the 
arterial wall. An increase in capillary resis- 
tance occurs after the application of various 
forms of stress and after the administration of 
ACTH/ 
131. 
ACTH and insulin, and it has been suggested that 
this increase in capillary resistance may be due 
to stimulation of adrenocortical activity 
(Robson & Duthie, 1950). Adrenalectomy in rats 
is followed by reduction of capillary resistance, 
which can subsequently be restored by cortisone 
( Kramar and Simy -Kramar, 1953). ACTH and 
cortisone also decrease capillary permeability 
and fibroblast activity, and thereby impair 
organisation of intravascular thrombi and minor 
injuries of the arterial intima (Payling -Wright, 
1954; Wang et al, 1955). Capillary permeability 
is increased in myxoedema and thyroxine therapy 
restores it rapidly to normal (Lange, 19í1J1). 
In addition to producing changes in the arterial 
wall it has long been observed that myxoedema 
is associated with marked degenerative changes 
in the muscle fibres of the myocardium (Ord, 1880) 
C. CONCLUSION. 
1. The main proposition of this thesis. 
The association of abnormalities of 
cholesterol metabolism, the coagulation system 
and the arterial wall with the development of 
coronary/ 
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coronary atherosclerosis and ischaemic heart 
disease has already been emphasised. Frank 
endocrine diseases and the administration of 
hormones can influence cholesterol metabolism, 
the fluid state of the blood and metabolism in 
the arterial wall, and it is postulated that 
the normal homeostasis of these three processes 
could be disturbed by alteration of the physio- 
logical endocrine balance. The thesis is pro- 
posed, therefore, that an endocrine imbalance 
could contribute to the development of coronary 
atherosclerosis and ischaemic heart disease. 
The principle weakness of this thesis 
lies in the fact that no marked and consistent 
abnormality of endocrine gland function has yet 
been found in patients who have the clinical 
features of coronary disease. It is unlikely 
that there is any gross endocrine disturbance 
in coronary atherogenesis as this would have wide 
metabolic repercussions and would have been 
recognised years ago, and it is possible that a 
comparatively minor disturbance may have passed 
largely unnoticed due to the crudeness of the 
available methods for assessing the function of 
the endocrine glands. However, there is some 
suggestive evidence that endocrine function may 




The basal metabolic rate was lower than 
normal in a group of patients who developed 
ischaemic heart disease under the age of 40, and 
it was concluded that their thyroid function might 
be slightly depressed (Lerman & White, 1946); thi 
observation has received confirmation recently 
(Gertler et al, 1953), but there was no significan 
difference in radioactive iodine excretion 
between coronary patients and euthyroid subjects. 
The concentration of circulating protein -bound 
iodine decreases with advancing age (Perlmutter 
& Pigf;s, 1949), but no clear correlation has been 
found between protein -bound iodine levels and 
coronary disease (Tucker Keys, 1951) although 
Marmorston et al (1955) found a greater depression 
of circulating protein -bound iodine in post- 
menopausal women with myocardial infarcts when 
compared with healthy postmenopausal controls. 
The relative freedom of premenopausal 
women from ischaemic heart disease is probably 
related to the endocrine differences between the 
sexes (see Pages 37,92) , and it is interesting to 
find that 30/% of women who developed ischaemic 
heart disease before the age of 40 had some 
endocrine/ 
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endocrine disturbance (Table XV). In view of 
the sex difference in the incidence of ischaemic 
heart disease and the depressant action of 
oestrogens on the circulating cholesterol, it 
might be expected that women who develop a 
myocardial infarct would excrete less oestrogen 
than a comparable control group, and biological 
determination of urinary oestrogen have indicated 
that this is so in two such groups of postmeno- 
pausal women (Marm_orston et al, 1955). When 
Dr. Bauld worked in the Department of Biochemistry 
at Edinburgh University, he started to estimate 
the urinary excretion of oestrogens in healthy 
men and men with ischaemic heart disease. These 
investigations (Bauld et al, 1956) suggested that, 
in response to an injection of estradiol -17 
f3 
the ratio of oestriol to oestrone was significantly 
elevated in men after myocardial infarction when 
contrasted with healthy men, although the total 
excretion of oestrogens was unchanged. This 
difference was not observed in 3 men, who did not 
have a myocardial infarct but were suspected of 
having clinical coronary disease. These two 
studies suggest that oestrogen metabolism might 
be/ 
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be disturbed in some patients with ischaemic 
heart disease. The proneness of males to 
ischaemic heart disease has led to an attempt 
to assess masculinity in such patients. Men 
who develop ischaemic heart disease under the 
age of 40 were considered to be morphologically 
more masculine than healthy men, but there was 
no consistent or significant difference in the 
excretion of 17- ketosteroids nor we's there any 
correlation between the circulating cholesterol 
levels and the 17- ketosteroid excretion 
(Gertler et al, 1953). Blood and urinary 
corticoid levels have not been reported in 
patients with ischaemic heart disease except 
immediately after an acute myocardial infarct. 
Thus endocrine gland function has not 
been carefully investigated in patients with 
angina and in patients who have recovered from a 
myocardial infarct; and, at present, the 
evidence obtained from standard tests of endocrine 
function is not adequate to refute or confirm 
the thesis that an endocrine imbalance might 
contribute to the development of coronary 
atherosclerosis. 
2. The aetiology of ischaemic heart disease. 
By/ 
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By 1955 20,E of all the deaths in Great 
Britain were due to arteriosclerotic or coronary 
heart disease and the crude death rate from 
ischaemic heart disease had increased seventyfold 
in half as many years, yet before this century 
angina was a rarity and coronary thrombosis had 
been diagnosed only once during life. There is 
good reason to believe that this remarkable 
dhange in the statistics of the disease represents 
a real increase in its prevalence, and attention 
must be directed, therefore, towards potentially 
deleterious influences which have developed during 
this century. There have been fundamental and 
far -reaching social and economic changes. The 
standard of living of the civilised nations has 
never been higher and has resulted in an 
abundance of food not previously experienced. 
Industrialisation and world wars have revolution- 
ised all our lives, and have created a new sense 
of strain and urgency and new responsibilities 
which many find difficult to withstand. 
a. Diet. 
In general, the intake of calories, 
protein and fat have increased with the rise in 
purchasing power which has followed the improvemen 
in/ 
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in the standard of living during this century. 
It is probably true to say that the physical 
activity and energy expenditure of many people 
has been reduced. There is now greater energy 
intake and less energy expenditure, and if energy 
intake exceeds energy expenditure, it is axiomatic 
that calories must be stored within the organism. 
Conservation of calories is most economically 
achieved by storing fat, which is deposited in 
many sites probably including the liver and 
arteries. When the intake of dietary calories 
is frequently in excess of the expenditure of 
calories by physical activity, a chronic dis- 
turbance of lipid metabolism might result. 
In countries where the incidence of 
ischaemic heart disease is low, the contribution 
of fat to total caloric intake is also low. As 
the percentage of calories derived from fat 
increases from the poorer to the richer nations 
so the incidence of ischaemic heart disease 
increases, and elaborate epidemiological 
surveys indicate a positive correlation between 
the social and geographic incidence of ischaemic 
heart disease with the consumption of fat (Keys 
and Anderson, 1954; Keys et al, 1955; Bronte- 
Stewart et al, 1955). In most civilised 
communities more than one -third of the total 
caloric/ 
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caloric intake is derived from fat, and it is 
possible that this habitual daily ingestion of 
large quantities of fat, particularly if mostly 
from animal sources, may disturb the homeostasis 
of lipid metabolism and favour the development 
of coronary atherosclerosis and of ischaemic 
heart disease; when the diet contains excessive 
fat the levels of the circulating lipids and 
-lipoproteins rise (Anderson and Keys, 1953; 
K_eys et al, 1955) and there is more frequent and 
greater development of postprandial lipaemia, 
which can accelerate blood coagulation (Fullerton 
et al, 1953; Poole, 1955; Robinson and Poole, 
1956) and inhibit fibrinolysis (Greig, 1956). 
b. Environmental "stress ". 
Even in countries where the fat consumptio 
is high, most of the population fortunately does 
not suffer from ischaemic heart disease; of 5 
men, whose environment and responsibilities are 
apparently closely comparable, only one may be 
expected to develop ischaemic heart disease. Ther 
is, then, an individual susceptibility, which is 
not well understood, but may be partly determined 
by heredity. The incidence of ischaemic heart 
disease/ 
disease is greatest in executive, professional, 
business and intellectual occupations, where 
heavy responsibilities often demand exacting and 
prolonged mental work (Ryle & Russell, 1949; 
Registrar- General for Scotland 1949 -1953; Report 
of Oslo Life Insurance Companies, 1956) (Fig. 36). 
The psychological strain and emotional tensions 
that often accompany these responsibilities are 
undoubtedly stressful to some people, particularly 
if they have inherited an ambitious and con- 
scientious personality, whereas others appear to 
be able to adapt themselves without undue 
difficulty. For example, the failure of certain 
inadequate personalities to adapt themselves to 
the environment can result in excessive appetite 
and disturbance of lipid metabolism with subseoue 
obesity (Hamburger, 1951; Brosin, 195L); this 
psychological production of obesity is probably 
mediated through the hypothalamus, which plays 
an important role in the control of appetite 
(Clark et al, 1938; Hetherington and Ranson, 
1940). In general, it is probably true to say 
that during this century competition has been 
keener and incentives have been fewer, and 
personal/ 
Fig. 36. The distribution of deaths from 
ischaemic heart disease between the 













personal financial and emotional stability has 
been less well balanced. Exactly what relation 
these changing environmental influences might 
have to the rapid development of ischaemic heart 
disease is at present obscure, but they should 
not be overlooked as aetiological factors of 
potential importance. 
c. Endocrine imbalance. 
It has already been postulated that an 
endocrine imbalance may favour the development 
of ischaemic heart disease and now some of the 
possible disturbances of normal endocrine balance 
will be considered. The nature and precision 
of each individual's endocrine balance may well 
be determined constitutionally and by heredity, 
and some individuals may be more susceptible 
than others to extraneous influences which tend 
to disturb this balance. Any primary endocrine 
dysfunction and particularly gross endocrine 
diseases will disturb the physiological hormonal 
balance. Failure to withstand environmental 
responsibilities might be transmitted to the 
endocrine system by way of the cerebral cortex 
and hypothalamus and result in disturbance of 
normal endocrine balance. Certainly acute 
"stress" 
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"stress" can lead to profound endocrine dis- 
turbances. For example, the normal pituitary- 
adrenocortical balance can be upset and lead to 
the various manifestations of the so- called "alarm 
reaction ", such as hypoglycaemia, gastrointestinal 
erosions, haemoconcentration and eosinopenia; 
the normal pituitary -thyroid balance can be 
upset by acute psychic stress, and the rapid 
development of thyrotoxicosis following a sudden 
severe shock or acute anxiety is common and well 
recognised; similarly, the normal pituitary- 
gonadal balance can 'also be upset by acute 
psychological duress, and the sudden cessation 
of menstruation following extreme emotional 
anxiety has often been described. Thus, the 
relationship between "stress" and disturbance 
of endocrine gland function might be close, and 
future investigations may indicate that the 
aetiological role, which has been postulated in 
this thesis, of an endocrine imbalance in the 
production of ischaemic heart disease could be 
partly dependent on increasing environmental 
"stress" and decreasing ability to cope with it. 
d. / 
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d. Ageing and local dynamic factors. 
Ageing and local dynamic factors are 
undoubtedly very important in the production of 
ischaemic heart disease, but there is nothing to 
suggest that they now have a greater influence 
on the development of coronary atheroma than they 
did thirty and forty years ago when ischaemic 
heart disease was uncommon; moreover, there is 
no satisfactory evidence that the incidence of 
coronary atheroma has increased. Advancing 
age results in progressive loss of elasticity 
leading to dilatation and stretching of the 
arterial wall. This gradual deterioration with 
age is something which elastic tissue has in 
common with many similar colloidal substances, 
and maybe the starting point of most of the 
changes which occur with ageing ( Ophüls, 1933). 
From early youth there is a tendency to splitting 
of the internal elastic lamina; at first this 
is not very marked but it becomes more and more 
complete with advancing age. Lansing (1955) has 
shown that the aminoacid composition of young and 
old arterial elastin is significantly different. 
Subintimal/ 
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Subintimal anoxaemia, fibrosis, lipid 
deposition and calcification can occur in 
arteries as a result of many local influences 
including differences in intimai thickness, 
elasticity tortuosity and intraluminal hydrostatic 
pressure. 
The possible aetiological relationship 
of diet, environment, endocrine imbalance and 
ageing is summarised in Fig. 37. 
Fig. 37. A speculative scheme showing some of 
the possible relationships between 
various aetiological factors which 
favour the development of ischaemic 
heart disease. 
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The presence and significance of 
abnormality of the circulating lipids and lipo- 
proteins in patients with ischaemic heart disease 
have already been described (Part II). The 
blood coagulation and fibrinolytic systems and the 
tonic and metabolic functions of the arterial 
walls may also be disturbed in patients who are 
prone to develop coronary atherosclerosis with 
subsequent ischaemic heart disease. It may be 
very important to prevent the deposition of 
microscopic films of fibrin on the arterial 
intima and to improve oxygenation to the arterial 
wall, but at present so little is known about 
these disturbances that no therapy can be 
devised to correct them. Anticoagulants are 
effective against the formation of frank intra- 
vascular thrombosis, but even this action is not 
entirely straightforward; for instance, anti- 
coagulants which cause hypoprothrombinaemia do 
not appear to retard clotting in vitro or in vivo 
(Wessler, 1953) and may achieve reduction in 
the incidence of thromboembolic episodes through 
some other action in addition to their anticoag- 
ulant properties (Gilchrist, 1952; Gilchrist & 
Tulloch/ 
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Tulloch, 1956). It has already been indicated 
that the abnormalities of blood coagulation and 
the disturbance within the arterial wall may be 
partially dependent on the presence of abnormal- 
ities in the circulating lipids and lipoproteins, 
and this section on therapy will, therefore, 
be concerned solely with the desirability and 
the possibilities of correction of these abnor- 
malities. 
A. THE TREATMENT OF HYPERCHOLESTEROLAEMIA. 
It would seem reasonable to assume that 
reduction of the cholesterol in the plasma might 
result in the passage of less cholesterol along 
with the physiological diffusion of crystalloids 
and colloids from the arterial lumen through the 
arterial wall to the veins and lymphatics of the 
adventitia. In the experimental animal the 
degree and extent of cholesterol deposition in 
the arterial wall is directly proportional to 
the degree of hypercholesterolaemia, thus re- 
duction of hypercholesterolaemia is followed 
experimentally by less cholesterol deposition. 
Similarly, any improvement in the stability of 
the colloidal dispersion of cholesterol in the 
plasma probably also results in a decreased 
tendency for cholesterol deposition./ 
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deposition. Such stability depends on the inter- 
relationship of cholesterol with other lipids, 
particularly the phospholipids, and with protein 
(see Pages 48 - 50); thus reduction of an 
elevated C/P ratio and of an elevated /3 :oK 
lipoprotein ratio might be regarded as desirable. 
Lipaemia can accelerate coagulation and inhibit 
fibrinolysis, and therefore correction of excessive 
and frequent episodes of lipaemia might also be 
beneficial. 
1. Diet. 
Consideration of some of the causes which 
could disturb the normal circulating lipids and 
lipoproteins and contribute also to the increasing 
incidence of ischaemic heart disease has implicated 
dietary fat (see Page 136), and restriction of the 
daily fat intake would therefore seem logical. A 
diet which is deficient only in cholesterol does 
not produce any significant reduction of the elevate 
circulating lipids and lipoproteins, but a diet low 
in fat lowers these values. 
a. Low fat diet. 
Twelve hypercholesterolaemic men have been 
studied over 4 years: 8 had had a myocardial 
infarct, 2 had angina and 2 were siblings of 
hypercholesterolaemic/ 
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hypercholesterolaemic patients with coronary 
disease. Two of the men, who had had a myo- 
cardial infarct, died during the period of study 
and the results reported in Fig. 38 have been 
obtained from the remaining 10 men. These subjects 
were selected as intelligent and cooperative men 
whose sedentary occupations would not demand a 
high caloric intake. It was appreciated from the 
start that a low fat diet would be unpalatable, 
monotonous and difficult to observe strictly, 
and so a small group of cooperative men, mostly 
in clerical occupations, were selected in 
preference to a larger and more varied group. 
The initial daily regime consisted of 1200 
calories with 20 g. of fat, or 15;i; of the total 
calories from fat. After 6 months this was 
increased in 7 men to 1600 calories with 26 g. 
of fat, which also represents 15% of the total 
calories from fat. One of the remaining 3 men 
received 1400 calories and 24 g. of fat, and the 
other 2 men received 1800 calories with 30 g. 
of fat. Thus, although there was some variation 
in the caloric intake, the contribution of fat 
never exceeded 15ió of the total. These men have 
been,/ 
Fig. 38. The mean changes in the circulating 
lipids following the ingestion of a low 
fat diet by 10 hypercholesterolaemic 
men with ischaemic heart disease. The 
average intake was approximately 11400 
calories and less than25 g. of fat; 
during the last year the diets may have 
been rather more liberal in calories 
but have never exceeded 2000 and more 
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been followed at 3 monthly intervals and it is 
believed that, while there may have been occasion- 
al lapses, they have observed their diets strictly. 
From Fig. 38 it can be seen that there was an 
initial rapid fall in plasma cholesterol and at 
the nadir this was associated with ketonuria, 
presumably indicating some endogenous mobilisation 
of fat reserves. This harsh dietary regime 
eventually achieved no more than a 15% reduction 
in plasma cholesterol. Even if more complete 
removal of fat from the diet could be tolerated 
for any length of time, no very striking reduction 
of plasma cholesterol would be expected as 
cholesterol is synthesised in the liver from 
active acett e derived from all three dietary 
elements, protein, carbohydrate and fat (see 
Page 51 ). A totally fat -free rice -fruit diet 
will, however, achieve marked reduction of plasma 
cholesterol (Kempner, 1948). 
It is concluded that severe restriction 
of dietary fat is unpleasant and often intolerable 
and does not achieve great reduction of the cir- 
culating lipids and lipoproteins, although 
dramatic effects can sometimes be achieved (Fig. 
39) . In/ 
Fig. 39. The changes in the circulating lipids 
and lipoproteins following the ingestion 
of a low fat diet by a patient with 
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In 1955 the average man in Great Britain received 
40,E of his calories from fat, and it is possible 
that less severe restriction of fat to between 
25% and 30% of the caloric intake might be more 
practical and might achieve slight reduction of 
the circulating lipids and lipoproteins. 
b. Vegetable oil diet. 
Evidence has been accumulating recently 
that an increase in the intake of vegetable fät 
causes depression of the circulating cholesterol, 
C/P ratio and A -lipoprotein cholesterol (Kinsell 
et al, 1952, 1953; Beveridge et al, 1955; 
Malmros and ":igand, 1955; Bronte- Stewart et al, 
1956). It appears that this effect o*egetable 
and fish oils is roughly but directly proportional 
to their lack of saturation and is probably re- 
lated to their essential fatty acid content. 
Whereas this effect of vegetable oils may lead to 
a practical therapeutic regime, at present an 
elaborate dietetic organisation is necessary to 
disguise the large quantity (200g) of oily 
emulsion which has to be swallowed each day. 
So far the author has not administered any vege- 
table oil to hypercholesterolaemic subjects but 
the/ 
1 51 . 
the administration of sunflower seed oil, which 
acted as a severe stomach and bowel irritant, to 
healthy young men did not induce any significant 
depression of cholesterol below normal levels. 
c. Plant Sterols. 
Sitosterol, a stereoisomer of cholesterol, 
reduces the absorption of cholesterol from the 
diet and the reabsorption of cholesterol excreted 
in the bile; this effect may be achieved by 
competition for esterification which is necessary 
for the absorption of most intestinal cholesterol. 
The administration of sitosterol is followed by 
some reduction in circulating cholesterol in most 
hypercholesterolaemic patients 1953). 
The daily oral administration of 10 g. of 
/ 
- 
sitosterol for 14 days to Li. hypercholesterolaemic 
men with coronary disease produced depression 
of the level of the circulating cholesterol by 10% 
and of the (3-lipoprotein cholesterol by 8%. Sito- 
sterol is a tasteless bran -like powder, which has 
to be sprinkled over all food making it dry and un- 
palatable. Plant sterols do not impair the ab- 
sorption of carbohydrate and protein, and the endo- 
genous synthesis of cholesterol is also unlikely 
to be affected. It is improbable, therefore, 
that/ 
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that plant sterols will have any useful thera- 
peutic application. 
d. Lipotrophic factors. 
Lipotrophic factors, such as choline and 
methionine, prevent fatty livers and are said to 
promote phospholipid synthesis thereby improving 
the transport and stability of cholesterol. 
Despite individual reports to the contrary, there 
has been no satisfactory evidence that they 
influence the circulating cholesterol in man 
(Davidson, 1951). The daily oral administration 
of 3 g. of choline chloride for 2 weeks to 6 
hypercholesterolaemic patients with ischaemic heart 
disease did not result in any significant change 
in the plasma cholesterol or C/P ratio. 
2. Hormones. 
Three groups of hormones have been shown 
to lower hypercholesterolaemia; they are 
pituitary- adrenocortical hormones (ACTH and 
cortisone), thyroid hormones and the oestrogenic 
sex hormones. Since ACTH and cortisone have 
fundamental and widespread metabolic actions in 
addition to their action on circulating cholesterol, 
they are obviously precluded from any attempt to 
achieve/ 
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achieve permanent reduction of hypercholesterol- 
aemia. Thyroid hormones and the oestrogenic 
sex hormones have not been administered for the 
control of hype_cholesterolaemia in many centres 
outside Edinburgh, and thus they will be considere 
in some detail. 
a. Thyroid hormones. 
The plasma cholesterol, C/P -ratio and 
A- lipoprotein cholesterol are all significantly 
depressed during administration of t -thyroxine 
sodium, t- triiodothyronine and triiodothyroacetic 
acid (triac) to euthyroid hypercholesterolaemic 
men with coronary disease; this influence of 
these thyroid derivatives has already been 
considered in detail (see Pages 115 - 119). 
Unfortunately thyroxine itself and these analogues 
of thyroxine increase the basal metabolic rate 
and thus increase the work and oxygen consumption 
of the myocardium When the blood supply is 
impaired by coronary atherosclerosis, any increase 
in the demands by the myocardium might be expected 
to result in temporary ischaemia and thus several 
of the men developed angina. This aspect of 





It has already been reported that 6 
euthyroid hypercholesterolaemic men with coronary 
disease received 600/Ág. of i- thyroxine sodium 
daily for 2 veeks with depression of the circul- 
ating lipids and lipoproteins and concomitant 
elevation of the basal metabolic rate by a mean 
of +13; (see Fig. 24) . Three of these men ex- 
perienced appreciable reduction of their exercise 
tolerance due to the development of effort angina, 
which regressed completely a few weeks after 
thyroxine had been discontinued. 
ii. Triiodothyronine 
Three euthyroid hypercholesterolaemic 
men_ with coronary disease received up to 10014g. 
of -triiodothyronine daily for f weeks with 
depression of the circulating lipids and lipo- 
proteins and concomitant elevation of the basal 
metabolic rate by a mean of +11 (see Fig. 25). 
Two of these 3 men experienced significant in- 
crease in the frequency of angina with subsequent 
regression when they received identical placebo 
tablets. 
A further 3 euthyroid hypercholesterol- 
aemic men with coronary disease received up to 
60/4g./ 
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60)14g. of 'e- trii.odothyronine daily over 7 weeks 
with depression of the circulating lipids and 
lipoproteins without any increase in basal 
Metabolic rate (see Fig. /40). However, one man 
rho had previously had an excellent exercise 
tolerance developed effort angina for the first 
time in 3 years; he had no rise in basal metabolic 
ate. 
iii. Triiodothyroacetic acid. 
Sig euthyroid hypercholesterolaemic men 
ruith coronary disease received from 0.5 mg. to 
mg. of triac daily over 95 days with depression 
.f the circulating lipids and lipoproteins above 
dose of 3mg. (see Fig. 26) . In two men there 
ias elevation of the basal metabolic rate by 20% 
:nd 13,E respectively. One of these two men and 
ne of the remaining four men, in whom there was 
o elevation of basal metabolic rate, complained 
.f marked reduction of exercise tolerance due to 
-ffort angina. When triac was withdrawn and 
lacebo tablets started both these men experienced 
apid regression of their symptoms and soon return - 
d to their norma4 exercise tolerance. 
A further 6 euthyroid hypercholesterol- 
:emic men with coronary disease received from 
.0/ 
Fig. 40. The changes in the circulating lipids 
and lipoproteins, and in the weight 
and basal metabolic rate, during the 
orale administration of Lß.0 and 60 i(,g. 
of L - triiodothyronine daily to 3 
euthyroid hypercholesterolaemic men 
with ischaemic heart disease. 
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3.0 to 5. 0 mg. of triac daily over 12 weeks with 
depression of the plasma cholesterol, 0/P ratio 
and /3-lipoprotein cholesterol at the 3 and 4 mg. 
dose levels (see Fig. L11). Despite the continued 
administration of 4 mg. of triac daily these 
values rose to the control levels, but there was 
a further slight fall when 5 mg. was administered 
daily although this was much less impressive than 
the original fall. Withdrawal of triac resulted 
in a rebound rise in the lipid and lipoproteins. 
The basal metabolic rate of these men was not 
significant altered, but one of these 6 men 
developed more angina and exertional bfeathlessness 
1957) 
with reduction of exercise tolerance(0liver & Boyd, 
In summary, 24 euthyroid hypercholesterol - 
aemic men with coronary disease, received thyroxine 
or one of its analogues. The circulating lipids 
and lipoproteins of them all were significantly 
lowered but 9 experienced definite reduction of 
exercise tolerance. This is readily understand- 
able in 6 men, whose basal metabolic rates were 
elevated, but less so in the remaining 3 men, in 
whom there was no elevation of basal metabolic 
rate. It is interesting, and possibly important 
therapeutically, that the circulating lipids and 
lipoproteins/ 
Fig. 41. The changes in the circulating lipids 
and lipoproteins, and in the basal meta- 
bolic rate and weight, during the oral 
administration of increasing large doses 
of triiodothyroacetic acid to 6 hyper - 
cholesterolaemic euthyroid men with 
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lipoproteins can be lowered by small doses of 
triiodothyronine and triiodothyroacetic acid 
without elevation of the basal metabolic rate 
(Figs. 26, 40 and lil). It has been demonstrated 
in rats that triac increases the oxygen uptake 
of heart tissue to a greater extent than that of 
liver, skeletal muscle and kidney (Barker & 
Lewis, 1956; Boyd & Oliver, 1957). The measure- 
ment of the basal metabolic rate cannot reflect 
the relative oxygen requirements of all the body 
tissues and hence the administration of a 
substance, which produces a biological response 
(plasma cholesterol depression) without influenc- 
ing the basal metabolic rate, may well alter the 
oxygen requirement of certain specific tissues. 
It is possible, therefore, that the dissociation 
of the action of triac on the circulating lipids 
and lipoproteins from any effect on the basal 
metabolic rate is more apparent than real, and 
may depend partly on inadequacy of the basal 
metabolic rate measurement to reflect a selective 
increase in the oxygen requirements of a com- 
paratively small tissue. Triac not only induced 
angina but also failed to mainttn depression of 
the/ 
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the circulating lipids and lipoproteins despite 
increasing doses (Fig. 41). It is concluded 
that it is unlikely that triiodothyronine or 
triac, despite their insignificant action on the 
basal metabolic rate, will prove suitable for the 
long -term control of hypercholesterolaemia in 
patients with clinical coronary disease. Future 
investigations should be directed towards the 
discovery of a thyroxine analogue which will not 
only depress the circulating lipids without 
altering the overall metabolic rate but also will 
not cause angina or any selective increase in 
oxygen uptake by heart tissue, 
b. Oestrogenic sex hormones. 
It has already been shown that the plasma 
cholesterol, the C/P ratio and the /5-lipoprotein 
cholesterol are all significantly and consistently 
depressed during the administration of any 
oestrogen (see Pages 119 - 122). Ethinyl oestra- 
diol produced the most significant depression of 
the circulating lipids and lipoproteins. The vast 
majority of the 125 men, who have received oestro- 
gens, have experienced gynaecomastia in varying 
degree, and in 2 of these men it was severe enough 
to cause withdrawal of the oestrogen preparation. 
egression/ 
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Depression of libido and loss of libido in older 
men occurred in 42% and nausea occurred 
occasionally. The frequency of these side 
effects of oestrogen therapy are listed in 
Table XXV. 
Table XXV. The side effects of oestrogen 
therapy in 125 hypercholesterolaemic 
men with coronary disease. 
Side effects Percentage of men 
Gynaecomastia 96% 
Depression or loss of libido 42/ 
Nausea 12% 
Penile irritation 3% 
Testicular pain 3% 
Despite the frequency of gynaecomastia and 
depression of libido it is remarkable how well 
two 
these /feminising effects have been tolerated. An 
4ttempt was made to minimise these feminising 
effects by the combined administration of an 
androgen or a progestin with ethinyl oestradiol. 
i. Androgen and oestrogen. 
(1) Methyl testosterone + ethinyl oestradiol: 
12 hypercholesterolaemic men with proven 
coronary disease were studied over 68 weeks. 
5 mg. of methyl testosterone were administered 
sublingually/ 
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sublingually each day for 4 weeks, and 10 mg for 
a further 4 weeks. During these 8 weeks the men 
also received inert tablets similar in size and 
shape to ethinyl oestradiol. At the end of 8 week 
tablets containing 4001,íg. of ethinyl oestradiol 
were substituted for the inert tablets, and for 
the next 14 weeks the men received increasing 
doses of ethinyl oestradiol and 10 mg of methyl 
testosterone daily; after the first 2 weeks 
6001,íg. of ethinyl oestradiol were administered 
each day and after 2 more weeks 800 p.g. then after 
2 further weeks 1 mg. of ethinyl oestradiol was 
administered daily. At the end of 14 weeks 
combined therapy inert sublingual tablets identica 
to the androgen were substituted, and the men 
received 1 mg. of ethinyl oestradiol daily for 4 
more weeks when idential inert tablets were again 
substituted for the oestrogen; the men then 
received two groups of inert tablets for a further 
12 weeks. 
The results of this study are shown in 
Fig. 42. The plasma cholesterol did not undergo 
any appreciable fall until a dose of 1 mg. of 
ethinyl oestradiol was reached, but when methyl 
testosterone/ 
Fig. 42. The changes in the circulating lipids 
during the combined oral administration 
of methyl testosterone and ethinyl oest- 
radiol to 12 hypercYxolesterolaemic men 
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testosterone was withdrawn, the plasma cholesterol 
fell by 21. C/P ratio did not undergo 
any appreciable fall until 800 pg. of ethiny; 
oestradiol was being received daily but when 
methyl testosterone was withdrawn, the C/P ratio 
fell by 23. 
(2) Ethinyl oestradiol + methyl testosterone. 
A further 12 hypercholesterolaemic men 
with proven coronary disease were studied for 
30 weeks. 200)4g. of ethinyl oestradiol were 
administered daily for 2 weeks, and thereafter 
up to the end of the 10th week the daily dose 
was increased by 200)11g. every 2 weeks. During 
these 10 weeks the men also receive inert subling- 
ual tablets similar in size, shape and taste to 
methyl testosterone sublingual tablets. At the 
end of these 10 weeks sublingual tablets con- 
taining 20 mg. of methyl testosterone were 
substituted for the inert tablets, and for the 
next 4 weeks the men received the androgen and 
1 mg. of ethinyl oestradiol daily. After L; weeks 
combined therapy inert tablets identical to the 
oestrogen were substituted, and the men received 
20 mg. of methyl testosterone daily for L. more 
weeks/ 
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weeks when inert sublin"ual tablets were again 
substituted for the androgen; the men then 
received two groups of inert tablets for a further 
Z: weeks. 
The results of this study are shown in 
Fig. 43. The plasma cholesterol fell by 25;6 
after 10 weeks of ethinyl oestradiol. When 
methyl testosterone was introduced, the plasma 
cholesterol rose by 35', and when ethinyl oestra- 
diol was withdrawn, the plasma cholesterol rose 
a further 12;x. The C/P ratio fell by 25% after 
10 weeks of ethiny] oestradiol. Then methyl 
testosterone was introduced,'the C/P ratio rose 
by 20, and when ethinyl oestradiol was withdrawn, 
the C/P ratio rose a further 19. 
The administration of methyl testosterone 
in these two studies not only failed to modify 
or prevent any of the side effects of ethinyl 
oestradiol, but resulted in partial inhibition 
of the depressant action of ethinyl oestradiol 
on the circulating lipids. 
ii. Progestin + oestrogen. 
Ethinyl testosterone + ethinyl oestradiol 
12 hypercholesterolaemic men with proven 
coronary/ 
Fig. L13. The changes in the circulating lipids 
during the combined oral administration 
of ethinyl oestradiol and methyl testo- 
sterone to 12 hypercholesterolaemic men 
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coronary disease were studied for 26 weeks. 
20 mg. of ethinyl testosterone (anhydro- 
hydroxyprogesterone) were administered sublingually 
each day for 2 weeks; thereafter 40 mg. were 
administered daily for 2 weeks and then 60 mg. 
were administered daily for the next 2 weeks. 
During these 6 weeks the men also received inert 
tablets similar in size and shape to ethinyl 
oestradiol. At the end of 2 weeks, tablets 
containing ethinyl oestradiol 500 jtg. were 
substituted for the inert tablets, and for the 
next 4 weeks the men received the oestrogen and 
60 mg. of the progesterone.analogue daily; 
after 2 weeks 1 mg. of ethinyl oestradiol was 
administered daily. At the end of 4 weeks of 
combined therapy inert sublingual tablets identical 
to the prokesterone analogue were substituted, and 
the men received 1 mg. of ethinyl oestradiol daily 
or 2 more weeks when identical inert tablets 
ere again substituted for the oestrogen; the 
nen then received two groups of inert tablets 
or a further 8 weeks. 
The results of this study are shown in 
z. . 44/ 
Fig. t4. The changes in the circulating lipids 
during the combined oral administration 
of anhydrohydroxyprogesterone (ethinyl 
testosterone) and ethinyl oestradiol 
to 12 hypercholesterolaemic men with 
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Fig. 111. The plasma cholesterol fell by 12, 
after 6 weeks of ethinyl testosterone. It fell 
by a further 10% when 1 mg. of ethinyl oestradiol 
was administered at the same time. There was 
a rise in plasma cholesterol by 18% when ethinyl 
testosterone was withdrawn even although the men 
were still receiving 1 mg. of ethinyl oestradiol 
daily, and there was a further rise on withdrawal 
of ethinyl oestradiol. The C/P ratio did not 
alter significantly during the 6 weeks when the 
men received ethinyl testosterone, but it fell 
by 13% when ethinyl oestradiol was introduced. 
The VP ratio subsequently rose by 29j following 
withdrawal of ethinyl oestradiol. This bombined 
administration of a progestin with ethinyl 
oestradiol failed to ameliorate any of the 
feminising side effects of oestrogen therapy. 
In summary, there is no doubt that the 
oestrogenic sex hormones lower the abnormal 
circulating lipids and lipoprotein patterns present 
in clinical coronary disease, but their feminising 
actions are likely to preclude them from any 
attempt at long -term control of hypercholesterol- 
aemic patients with clinical coronary disease. 
Nevertheless,/ 
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Nevertheless, a long -term study or the effect 
of oestrogens on the circulating lipids and 
on the rates or morbidity and mortality from 
ischaemic heart disease is being conducted. The 
subjects are 100 men wish proven myocardial 
infarction; these men were discharged consecu- 
tively from Ward 22 of the Royal Infirmary and 
ever since alternate cases have received 200)ug. 
of ethinyl oestradiol daily or identical inert 
tablets. The men attended as outpatients every 
3 months during the first year after discharge 
from the ward and have attended 6 monthly there- 
after; the clinical features, blood pressure, 
weight and a blood specimen for lipid analysis 
have been assessed at each visit, and an electro- 
cardiogram has been recorded at every second 
visit. The majority have been followed for 12 
years and 25 for more than 2 years. The effect 
of ethinyl oestradiol on the circulating lipids 
is shown in Fig. 45. In contrast to triiodothyro- 
acetic acid, ethinyl oestradiol maintains de- 
pression of the plasma cholesterol and C/P ratio 
over long periods; the greater effect on the C/P 
ratio emphasises that oestrogens/ 
Fig. 45. The changes in the circulating lipids 
during the oral administration of 200 
iug. of ethinyl oestradiol daily on a 
long -term basis. The number of cases 
in the control group and oestrogen 











_o -o CONTROL GROUP 
OESTROGEN TREATED 
GROUP 
NUMBER OF CASES IN 
(I) CONTROL GROUP 50 50 50 46 34 31 23 II 
(2) OESTROGEN TREATED GROUP 50 50 49 47 41 38 28 14 
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oestrogens cause elevation of the phospholipids 
as well as depression of cholesterol. Up to 
the present there have been 6 deaths in the oes- 
trogen treated group and Li- deaths in the control 
group; it is unlikely that this study will give 
any reliable or valuable information concerning 
the influence of lowered circulating lipids on 
morbidity and mortality until it has been pursued 
for 5 years. 
3. Miscellaneous. 
Several miscellaneous substances such 
as large doses of heparin (Basu & Stewart, 1952), 
nicotinic acid (Altschul & Herman, 1955), 
chelating agents (Perry & Schroeder, 1955), and 
phenyl ethyl acetic acid (Mathivat & Cottet, 
1953) have been reported to lower plasma cholest- 
erol. 
Phenyl ethyl acetic acid, or'ayposterol ", 
has been administered at three dose levels to 18 
hypercholesterolaemic men with proven coronary 
disease. No significant change was produced in 
6 men during the daily oral administration of 
1.2 g.. (optimum dose according to the original 
investigators) for 12 weeks or in a further 6 men 













































































































































































































































































































































































































for 4 weeks. However, the daily oral 
administration of 5 & to a further 6 men resulted 
in slight depression of the mean plasma cholest- 
erol by 17% (Table XXVI). Although apparbntly 
not toxic after a few weeks, phenyl ethyl acetic 
gcid has not yet been administered over long 
periods. At present it is not regarded as a 
potent cholesterolytic agent. 
B. CONCLUSION. 
At present there is no really effective 
acceptabile method of lowering hypercholesterol- 
aemia. Restrictions or alterations of the diet 
are unpleasant and monotonous, and do not achieve 
any very marked or consistent depression of 
hypercholesterolaemia. Thyroid analogues and 
oestrogens achieve the most marked and consistent 
depression of the elevated circulating lipids 
and lipoproteins but the former increase myocardi 
metabolism even in the absence of any effect on 
the basal metabolic rate, and the lattdr induce 
feminisation to a greater or lesser degree in 
every subject. It is possible that intensive 
investigation of new thyroid analogues will lead 
to a derivative which will have little or no 
effect/ 
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effect on metabolism but continue to depress 
cholesterol. It is also possible that a 
"non- feminising oestrogen" will be developed, 
although such a preparation may also lose its 
cholesterolytic action. 
It is on a study of prognosis, and not 
on a study of reduction of circulating cholest- 
erol that the efficiency of any particular regime 
must be judged. It is fundamental to determine 
whether correction of the abnormal circulating 
lipids and lipoproteins is associated with an 
improvement in morbidity and mortality, and 
particularly with inhibition or even regression 
of the atherosclerotic lesions. This is 
obviously difficult to investigate in man, althou- 
gh some indication that the atherosclerotic pro- 
cess might be halted is obtained from two recent 
studies. Autopsies of middle -aged men who died 
in Russian prisoner -of -war camps after months 
or years of extreme hunger, and autopsies of men 
who died during the hunger blockade of 
Leningrad in 1942 were remarkable for the fre- 
quent absence of any atherosclerosis in the 
coronary arteries and for the very rare occurrence 
of/ 
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of significant atherosclerotic lesions; moreover, 
myocardial infarcts were practically never found 
(Pierach, 1955). Similarly, autopsies of men, 
who died from carcinoma of the prostate after 
receiving large doses of oestrogens, showed less 
coronary atherosclerosis than a comparable control 
group (Rivin & Dimitroff, 1953). It is encour- 
aging to think that the atherosclerotic process 
might have been retarded in the subjects of 
these studies. Yet once atherosclerotic lesions 
have become extensive and severe enough to 
produce clinical features of ischaemic heart 
disease, inhibition of the atherosclerotic pro- 
cess may not necessarily prolong life; when an 
efficient and acceptable therapy can be proved 
to retard the atherosclerotic process in the 
human, it should probably be offered primarily 
to the younger and apparently healthy members of 
the community. Any such prophylactic regime 
will depend on the perfection of reliable tests 
so that those individuals who are likely to 
develop ischaemic heart disease can be selected 
with certainty from the healthy population. 
170. 
SUMMARY 
The early history, the nature and the 
incidence of coronary atherosclerosis and 
ischaemic heart disease have been reviewed. 
Evidence has been presented to suggest that there 
are aetiological factors which favour the develop- 
ment of ischaemic heart disease without influencin 
the incidence of coronary atherosclerosis. 
The close relationship of cholesterol 
metabolism to coronary atherosclerosis and to 
ischaemic heart disease has been emphasised. 
The circulating lipids and lipoproteins 
have been studied in health in relation to age 
and sex. They were abnormal in the majority 
of patients with ischaemic heart disease, 
particularly in those under the age of 50. 
Analysis of the circulating lipids and lipoprotein 
could aid the solution of an equivocal diagnosis 




The effects of endogenous hormones and 
the action of administered hormones on the 
circulating lipids and lipoproteins have been 
described in detail. Hormones can also 
influence the fluid state of the blood and the 
tonicity and metabolism of arteries. It has 
been postulated that the homeostasis of cholest- 
erol metabolism, of the fluid state of the blood 
and of arterial metabolism could be disturbed 
by alteration of the physiological endocrine 
balance. 
The thesis has been proposed that an 
endocrine imbalance could contribute to the 
development of coronary atherosclerosis and of 
ischaemic heart disease. The relationship of 
this thesis to existing theories of the aetiology 
of ischaemic heart disease has been considered 
in detail. 
Finally, some therapeutic implications of 
these metabolic and endocrine aspects of coronary 
disease have been considered. 
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